Hypothyroidism (congenital or acquired)

HYPOTHYROIDISM

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints E4_CONGEIOD E4_IODGOITRE E4_IODTHYR E4_IODHYPSUB E4_HYTHYSUBS E4_HYTHYPOSTINF E4_ATROTHY E4_MYXOCO E4_HYTHYNAS	66396
6. Filter based on genotype QC (FinnGen only)	66396

Control definitions (FinnGen only)

Control exclude: NEURO_COMORBIDITIES

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	HYPOTHYROIDISM
CONTROL_EXCLUDE	NEURO_COMORBIDITIES
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	E4_CONGEIOD\|E4_IODGOITRE\|E4_IODTHYR\|E4_IODHYPSUB\|E4_HYTHYSUBS\|E4_HYTHYPOSTINF\|E4_ATROTHY\|E4_MYXOCO\|E4_HYTHYNAS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Hypothyroidism (congenital or acquired) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	66396	53052	13344
Unadjusted period prevalence (%)	15.63	18.08	5.88
Median age at first event (years)	52.68	50.84	59.99

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4176: Matched controls
34263

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

E03

ICD-10 Finland

Other hypothyroidism

182.5

323.0

657

N05AH03

ATC

olanzapine; systemic

317.1

323.0

389

215

Kela drug reimbursment

Diabetes, non-insulin-treated

7775.2

323.0

783

N05BA04

ATC

oxazepam; oral

11.0

323.0

791

713

N06AB10

ATC

escitalopram; oral

18.3

323.0

932

528

N06AX11

ATC

mirtazapine; oral

8.6

323.0

1147

1449

T90

ICPC

Diabetes non-insulin dependent

43.2

323.0

452

F32.9

ICD-10 Finland

Depressive episode, unspecified

24.3

323.0

730

296

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

425.6

323.0

1602

E03.89

ICD-10 Finland

Other specified hypothyroidism

271.2

323.0

388

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

1188.4

323.0

394

N05AH04

ATC

quetiapine; oral

24.7

323.0

960

410

N06AB03

ATC

fluoxetine; oral

38.5

323.0

442

105

C07AB07

ATC

bisoprolol; oral

9.1

323.0

900

1003

104

Kela drug reimbursment

Thyroid insufficiency

+∞

323.0

756

103

Kela drug reimbursment

Diabetes, insulin-treated

7861.5

323.0

790

E03.80

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

488.1

323.0

523

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

80.8

323.0

433

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

+∞

323.0

423

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

30.9

323.0

494

148

A10BA02

ATC

metformin; oral

52.8

323.0

579

104

N06AX16

ATC

venlafaxine; oral

72.2

323.0

662

A10AE04

ATC

insulin glargine; parenteral

1731.7

323.0

401

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

903.4

323.0

399

N06AB06

ATC

sertraline; oral

33.5

323.0

498

138

N06AB04

ATC

citalopram; systemic

23.6

323.0

646

264

T86

ICPC

Hypothyroidism/myxoedema

340.9

323.0

482

N06AX12

ATC

bupropion; oral

66.2

323.0

416

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

93.7

323.0

403

H03AA01

ATC

levothyroxine sodium; systemic

9516.2

323.0

4081

128

SPAT1262

SPAT

Handing over of treatment supplies

17.1

322.0

554

303

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

14.3

315.2

584

385

N05AX12

ATC

aripiprazole; systemic

408.2

302.7

323

BAA60

NOMESCO Finland

Total thyroidectomy

472.0

301.4

320

205

Kela drug reimbursment

Chronic hypertension

+∞

299.4

306

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

157.6

299.0

336

T89

ICPC

Diabetes insulin dependent

692.5

297.9

313

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

9.8

292.7

657

642

N05AX08

ATC

risperidone; systemic

89.8

288.4

342

A10AE05

ATC

insulin detemir; parenteral

+∞

286.5

293

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

2324.8

265.3

274

H04AA01

ATC

glucagon; nasal, parenteral

797.5

260.3

273

GD1AA

NOMESCO Finland

Thorax X-ray examination

4.1

253.0

1208

3063

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

+∞

251.8

258

N06AX26

ATC

vortioxetine; oral

54.3

245.9

313

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

287.6

244.3

265

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

142.5

243.3

276

N06AX21

ATC

duloxetine; oral

28.5

238.6

348

109

N05CF01

ATC

zopiclone; oral

5.6

235.2

784

1349

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

8.4

232.5

569

633

C07AA05

ATC

propranolol; systemic

5.5

224.9

760

1324

F29

ICD-10 Finland

Unspecified nonorganic psychosis

506.8

220.2

234

N03AX09

ATC

lamotrigine; oral

31.5

220.1

313

I10

ICD-10 Finland

Essential (primary) hypertension

4.4

217.2

944

2149

H03BB01

ATC

carbimazole; oral

31.3

214.3

305

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

+∞

206.5

212

N05AA02

ATC

levomepromazine; systemic

189.5

196.9

219

A02BC02

ATC

pantoprazole; systemic

2.8

189.6

1835

7544

C03CA01

ATC

furosemide; systemic

24.7

189.4

287

102

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

8.8

185.7

436

446

N05AN01

ATC

lithium; oral

420.0

183.1

196

A10AE06

ATC

insulin degludec; parenteral

+∞

182.9

188

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

5.7

182.1

588

953

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

335.4

181.6

196

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

411.0

179.2

192

A10AA02

ATC

1523.2

178.7

186

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

29.9

178.6

257

N03AG01

ATC

valproic acid; systemic, rectal

13.5

176.8

332

217

P76

ICPC

Depressive disorder

13.1

175.6

335

227

A10AA01

ATC

1636.2

174.8

182

C10AA05

ATC

atorvastatin; oral

4.8

168.2

642

1253

C10AA01

ATC

simvastatin; oral

5.2

168.2

588

1042

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

+∞

163.3

168

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

23.7

161.9

248

T36

ICD-10 Finland

Poisoning by systemic antibiotics

22.6

159.0

247

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

249.4

158.8

174

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

6.5

158.5

456

631

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

158.4

163

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

7.1

156.3

423

537

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

76.9

155.3

188

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

8.9

153.7

357

355

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

+∞

153.5

158

G47.3

ICD-10 Finland

Sleep apnoea

3.6

152.4

824

2202

C08CA01

ATC

amlodipine; oral

5.1

151.9

545

988

N05BA01

ATC

diazepam; systemic, rectal

6.5

148.7

427

588

C09AA05

ATC

ramipril; oral

8.7

148.4

349

354

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

93.6

148.0

175

A10BK03

ATC

empagliflozin; oral

444.5

146.8

157

E11

ICD-10 Finland

Type 2 diabetes mellitus

19.2

146.1

239

108

N02BE01

ATC

paracetamol; systemic, rectal

2.4

144.7

2931

16943

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

1311.6

144.5

151

E10

ICD-10 Finland

Type 1 diabetes mellitus

1301.4

143.5

150

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

31.5

141.6

201

Z01.0

ICD-10 Finland

Examination of eyes and vision

4.0

136.8

626

1440

EP1AE

NOMESCO Finland

Neck ultrasound examination

10.8

133.8

279

226

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.8

133.5

655

1600

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

54.5

130.6

166

H02AB09

ATC

hydrocortisone; systemic

20.2

130.1

209

F34.1

ICD-10 Finland

Dysthymia

37.8

130.1

177

XX7CT

NOMESCO Finland

Radioiodine therapy of thydoid tissue

1160.6

129.9

136

N03AX16

ATC

pregabalin; oral

4.2

129.6

557

1205

I25.1

ICD-10 Finland

Atherosclerotic heart disease

107.1

129.5

151

N06AB05

ATC

paroxetine; oral

22.2

128.8

201

F41.1

ICD-10 Finland

Generalized anxiety disorder

11.3

127.4

259

199

N05AH02

ATC

clozapine; systemic

+∞

127.1

131

N05AF03

ATC

chlorprothixene; systemic

1130.8

126.9

133

A10BH01

ATC

sitagliptin; oral

1130.8

126.9

133

XCK10

NOMESCO Finland

Photography of fundus of eye

10.1

126.8

273

235

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

+∞

126.1

130

R53

ICD-10 Finland

Malaise and fatigue

3.4

125.8

715

1959

B01AA03

ATC

warfarin; systemic

39.0

125.0

169

N05AB03

ATC

perphenazine; systemic, rectal

103.4

124.8

146

E66.01

ICD-10 Finland

Obesity due to excess calories

7.0

123.9

337

427

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

29.5

122.2

176

N05BA12

ATC

alprazolam; oral

11.1

121.3

249

195

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

8.0

121.0

300

330

P03

ICPC

Feeling depressed

4.2

120.2

511

1090

SPAT1240

SPAT

Therapeutic discussion

3.8

119.4

582

1405

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

353.5

116.8

126

N05BA06

ATC

lorazepam; systemic, sublingual

90.0

116.2

138

C09AA02

ATC

enalapril; systemic

7.1

115.6

308

378

F32.1

ICD-10 Finland

Moderate depressive episode

9.9

115.2

250

218

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

8.3

114.6

277

292

N05CD07

ATC

temazepam; oral

18.6

114.6

189

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

63.5

114.4

142

AA1AD

NOMESCO Finland

CT of head and brain

4.2

113.7

489

1052

SPAT1249

SPAT

Treatment-related counselling outside office

2.3

113.1

1465

6547

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

9.8

110.9

242

213

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

+∞

110.5

114

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

+∞

110.5

114

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

17.4

109.6

185

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

109.5

113

H3600, E103

ICD-10 Finland

+∞

109.5

113

I48

ICD-10 Finland

Atrial fibrillation and flutter

98.4

108.9

128

WX408

NOMESCO Finland

General anesthesy, balanced

2.8

108.6

858

2923

F40.1

ICD-10 Finland

Social phobias

19.0

107.6

176

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

105.7

107.1

125

130

Kela drug reimbursment

Malignant tumour

+∞

106.6

110

XF400

NOMESCO Finland

ECG with 12 standard connections

5.1

105.4

371

648

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

318.6

105.2

114

F31.8

ICD-10 Finland

Other bipolar affective disorders

166.0

105.0

118

101

Kela drug reimbursment

Anterior pituitary hypofunction

21.5

104.4

164

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

58.2

104.2

131

N05CF02

ATC

zolpidem; oral

4.0

104.2

472

1061

C10AA07

ATC

rosuvastatin; oral

4.2

103.1

442

944

177

Kela drug reimbursment

Insulin glargine 300 U / ml

908.6

102.7

108

P29

ICPC

Psychological sympt/compl other

5.3

102.1

344

571

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

6.9

101.0

276

350

IGY02

NOMESCO Finland

Psychiatric monitoring contact

50.0

100.9

130

F32

ICD-10 Finland

Depressive episode

10.2

100.8

215

181

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

891.3

100.7

106

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

188.7

100.6

112

TPH04

NOMESCO Finland

Cathetrisation of vein

3.4

99.9

560

1501

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

187.0

99.6

111

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

+∞

97.8

101

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

96.9

100

P99

ICPC

Psychological disorders other

18.9

96.5

158

N05BE01

ATC

buspirone; oral

54.2

96.0

122

E66.8

ICD-10 Finland

Other obesity

11.4

94.6

191

144

E23.00

ICD-10 Finland

Panhypopituitarism

150.1

94.6

107

P01

ICPC

Feeling anxious/nervous/tense

2.9

94.2

663

2081

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

830.9

93.9

N02AX02

ATC

tramadol; systemic, rectal

2.4

93.9

1043

4247

F93.89

ICD-10 Finland

Other childhood emotional disorders

418.7

93.2

100

N06AX22

ATC

agomelatine; oral

68.1

92.0

113

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

15.8

91.7

160

R06.0

ICD-10 Finland

Dyspnoea

3.1

91.2

578

1687

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

5.2

91.0

309

516

F20.9

ICD-10 Finland

Schizophrenia, unspecified

+∞

91.0

D44.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thyroid gland

49.3

90.7

117

F90.0

ICD-10 Finland

Disturbance of activity and attention

9.4

90.1

201

184

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

4.2

89.9

383

810

P74

ICPC

Anxiety disorder/anxiety state

8.2

88.4

214

225

IGY99

NOMESCO Finland

Other psychiatric treatment contact

61.8

88.4

110

N03AE01

ATC

clonazepam; systemic

14.4

87.3

158

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.2

87.2

1201

5379

N05AD01

ATC

haloperidol; systemic

138.6

87.0

WZC30

NOMESCO Finland

Teaching

4.4

86.3

348

697

C07AB02

ATC

metoprolol; systemic

7.4

86.3

222

257

B01AB05

ATC

enoxaparin; parenteral

3.3

85.5

488

1315

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.6

84.1

430

1064

R5140

NOMESCO Finland

Monitoring the use of the aid

4.2

83.8

353

737

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

77.2

83.6

101

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

736.4

83.3

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

+∞

83.2

F61.0

ICD-10 Finland

Mixed personality disorders

132.9

83.2

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.6

82.5

712

2513

F41.09

ICD-10 Finland

UNS Panic Syndrome

16.6

82.4

141

N02AA05

ATC

oxycodone; systemic

8.0

82.3

202

217

A10BK01

ATC

dapagliflozin; oral

727.9

82.3

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

11.0

82.2

168

130

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

23.5

81.9

125

Z01.8

ICD-10 Finland

Other specified special examinations

2.7

81.6

637

2118

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

719.3

81.3

H3601, E103

ICD-10 Finland

+∞

81.3

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

32.0

81.0

114

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

4.8

80.9

296

536

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

74.8

80.9

N06BA04

ATC

methylphenidate; oral

11.3

80.7

163

123

B01AC04

ATC

clopidogrel; oral

21.7

80.7

126

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

3.3

80.5

455

1215

N06AG02

ATC

moclobemide; oral

40.9

80.2

107

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

29.4

80.1

115

WX402

NOMESCO Finland

General anaesthesia

3.0

79.9

530

1587

M79.6

ICD-10 Finland

Pain in limb

2.2

79.8

1001

4269

N06AX03

ATC

mianserin; oral

42.0

79.1

105

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

7.7

78.8

198

221

A03FA01

ATC

metoclopramide; systemic, rectal

4.0

77.7

345

755

N03AX12

ATC

gabapentin; oral

4.0

77.5

348

769

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

7.3

77.4

201

236

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

145.7

76.8

H3603, E103

ICD-10 Finland

+∞

76.4

A10AD01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

+∞

76.4

A11CC03

ATC

alfacalcidol; systemic

42.4

76.2

101

R07.4

ICD-10 Finland

Chest pain, unspecified

2.8

76.2

568

1829

F51.0

ICD-10 Finland

Nonorganic insomnia

3.2

76.1

450

1241

N07BB01

ATC

disulfiram; oral

7.3

76.1

197

230

XF404

NOMESCO Finland

Ambulatory ECG

9.7

76.0

166

146

A06AC01

ATC

ispaghula (psylla seeds); oral

3.2

76.0

462

1301

TPH07

NOMESCO Finland

Cathetrisation of artery

7.4

75.9

195

225

R03AC02

ATC

salbutamol; inhalant

1.9

75.5

1831

10094

C03DA01

ATC

spironolactone; oral

13.5

75.3

140

E66.00

ICD-10 Finland

Metabolic syndrome

9.5

75.0

165

147

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

23.4

74.7

114

H02AB06

ATC

prednisolone; systemic

2.0

74.6

1277

6182

C10AX09

ATC

ezetimibe; oral

9.1

74.4

168

157

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

15.6

73.7

129

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

+∞

73.5

P72

ICPC

Schizophrenia

+∞

73.5

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

5.6

73.1

231

353

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

2.0

73.1

1183

5591

F99

ICD-10 Finland

Mental disorder, not otherwise specified

37.8

73.1

WX892

NOMESCO Finland

Monitored bed care

7.9

73.0

180

195

J01DB01

ATC

cefalexin; oral

1.9

72.8

3117

20750

A02BC01

ATC

omeprazole; systemic

2.6

72.7

605

2079

E89.00

ICD-10 Finland

Postirradiation hypothyroidism

169.3

72.3

N06AX05

ATC

trazodone; oral

48.7

72.0

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

4.9

71.9

256

449

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.8

71.8

518

1633

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

633.9

71.7

SPAT1263

SPAT

Sampling

1.9

71.6

1553

8182

207

Kela drug reimbursment

Chronic arrhythmias

220.6

71.6

I50.9

ICD-10 Finland

Heart failure, unspecified

+∞

71.6

AN1

Coronary angiography

43.8

71.4

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

135.5

71.1

F31

ICD-10 Finland

Bipolar affective disorder

114.3

70.9

SPAT1301

SPAT

No procedures

2.1

70.7

1024

4615

Z71.8

ICD-10 Finland

Other specified counselling

2.2

70.6

883

3731

WX110

NOMESCO Finland

Local anesthesy

1.8

70.1

2808

18114

XF402

NOMESCO Finland

ECG with work load test

7.8

69.9

174

191

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

+∞

69.6

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

17.4

69.2

116

S18

ICPC

Laceration/cut

2.0

69.1

1125

5308

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

16.6

69.1

118

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

160.8

68.5

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

6.5

67.9

191

251

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

46.1

67.5

T82

ICPC

Obesity

8.4

67.4

159

160

SPAT1260

SPAT

Consultation of another employee

2.6

67.1

561

1927

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.8

66.7

1682

9269

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

3.8

66.5

312

715

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

10.6

66.1

137

109

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

203.1

65.9

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

582.9

65.9

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

+∞

65.8

JN4BD

NOMESCO Finland

Extensive body CT

7.2

65.7

171

201

C09CA01

ATC

losartan; oral

3.2

65.5

378

1020

A02BC05

ATC

esomeprazole; systemic

2.1

65.5

957

4306

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

294.3

65.3

R42

ICD-10 Finland

Dizziness and giddiness

3.0

64.8

421

1233

P06

ICPC

Sleep disturbance

3.3

64.8

365

967

SPAT1097

SPAT

Recording of ECG

4.3

64.5

260

518

A10BJ06

ATC

semaglutide; parenteral

+∞

63.8

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

18.6

63.5

104

R4110

NOMESCO Finland

Physiotherapy

2.4

63.3

618

2303

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

31.1

63.0

N06AA09

ATC

amitriptyline; systemic

8.5

62.2

146

N06CA01

ATC

amitriptyline and psycholeptics; systemic

6.8

62.1

168

209

H36.00

ICD-10 Finland

Diabetic background retinopathy

548.9

62.0

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

28.7

61.8

UJF32

NOMESCO Finland

Coloscopy

2.7

61.2

464

1500

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

189.0

61.1

D64.9

ICD-10 Finland

Anaemia, unspecified

10.9

61.1

125

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

2.2

61.0

721

2946

A04

ICPC

Weakness/tiredness general

2.5

60.9

529

1848

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

+∞

60.9

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

+∞

60.9

N06AA12

ATC

doxepin; systemic

20.6

60.7

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.9

60.2

1151

5716

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.8

60.1

441

1396

N04AA02

ATC

biperiden; systemic

141.7

59.9

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

+∞

59.9

R50.9

ICD-10 Finland

Fever, unspecified

2.5

59.9

520

1815

E06.3

ICD-10 Finland

Autoimmune thyroiditis

32.0

59.9

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

4.2

59.3

243

491

H02AB02

ATC

dexamethasone; systemic

14.3

59.2

107

F39

ICD-10 Finland

Unspecified mood [affective] disorder

27.7

59.2

R11

ICD-10 Finland

Nausea and vomiting

3.8

59.2

277

632

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

95.9

58.7

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

9.6

58.1

127

112

SPAT1307

SPAT

Psychosocial counselling and guidance

2.8

58.1

419

1312

TFP20

NOMESCO Finland

Cardiodefibrillation

+∞

58.0

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

60.2

57.8

TK800

NOMESCO Finland

Hemodialysis

50.8

57.1

F41.00

ICD-10 Finland

Moderate panic disorder

59.3

56.9

BAA40

NOMESCO Finland

Unilateral lobectomy of thyroid gland

20.4

56.8

C08CA13

ATC

lercanidipine; oral

7.3

56.5

145

167

SPAT1310

SPAT

Counselling related to known health issue

1.9

56.2

1137

5733

SPAT1148

SPAT

Treatment of chronic ulcer or burn

3.9

56.2

253

558

XCW99

NOMESCO Finland

Other investigative procedure of eye

3.8

56.0

259

585

ZX114

NOMESCO Finland

Intramuscular

16.1

55.8

127

Kela drug reimbursment

Transplant complication

41.2

55.7

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.5

55.6

492

1733

SPAT1234

SPAT

Support of social functional capacity

12.8

55.5

105

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

49.3

55.3

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

45.5

54.5

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

3.7

53.9

260

608

A49.9

ICD-10 Finland

Bacterial infection, unspecified

5.4

53.8

173

270

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

20.3

53.6

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.5

53.2

488

1750

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

+∞

53.2

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

4.3

52.9

212

419

F60.9

ICD-10 Finland

Personality disorder, unspecified

41.7

52.9

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

13.0

52.7

A06AD11

ATC

lactulose; oral

4.0

52.5

231

499

E23.04

ICD-10 Finland

Hypogonadotropic hypogonadism

8.2

52.3

125

129

N06AB08

ATC

fluvoxamine; oral

75.0

52.2

P01AB01

ATC

metronidazole; oral, rectal

1.9

52.1

899

4260

EBA15

NOMESCO Finland

Extraction of large number of teeth

8.6

52.1

121

119

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.1

52.0

692

2960

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.3

52.0

534

2029

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

6.8

51.6

140

175

A10BD07

ATC

metformin and sitagliptin; systemic

455.9

51.5

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

+∞

51.2

JN5AQ

NOMESCO Finland

SPECT of thyroid metastasis with low-dose CT

+∞

51.2

N05AE04

ATC

ziprasidone; systemic

+∞

51.2

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

+∞

51.2

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

7.5

50.5

127

142

A28

ICPC

Limited function/disability NOS

6.1

50.5

148

206

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

7.3

50.4

130

151

WX872

NOMESCO Finland

Intensive care

16.9

50.4

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

58.4

50.4

I47.1

ICD-10 Finland

Supraventricular tachycardia

27.7

50.4

SPAT1222

SPAT

Counselling/guidance promoting independent living

3.1

50.4

311

877

A46

ICD-10 Finland

Erysipelas

3.1

50.3

309

868

AA400

NOMESCO Finland

Electroconvulsive therapy

+∞

50.2

R51.80

ICD-10 Finland

Headache

2.3

50.1

531

2044

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.6

49.8

2007

12351

XA800

NOMESCO Finland

Neuropsychological investigation

6.1

49.6

145

201

K02.1

ICD-10 Finland

Caries of dentine

1.6

49.4

2494

16286

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

71.4

49.4

R4190

NOMESCO Finland

Nutritional therapy

6.4

49.2

139

184

E66.9

ICD-10 Finland

Obesity, unspecified

7.1

49.2

128

151

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

6.8

49.1

133

166

C09CA06

ATC

candesartan; oral

2.6

48.6

410

1402

RD210

NOMESCO Finland

9.4

48.6

107

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.9

48.5

217

475

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

70.2

48.5

J01FF01

ATC

clindamycin; systemic

2.0

48.5

753

3419

F33

ICD-10 Finland

Recurrent depressive disorder

25.0

48.4

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

+∞

48.3

WX002

NOMESCO Finland

Sedation and analgesia

2.6

48.2

392

1311

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

9.4

48.2

106

JN4AD

NOMESCO Finland

Body CT examination

10.8

47.6

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

+∞

47.3

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

216.3

47.2

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

216.3

47.2

J01AA02

ATC

doxycycline; systemic

1.6

47.1

2181

13838

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.7

46.7

1304

7203

CKC12

NOMESCO Finland

Photocoagulation of retina

7.6

46.6

116

128

F10.20

ICD-10 Finland

Alcohol dependence currently independent

17.1

46.5

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

+∞

46.4

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

+∞

46.4

SPAT1243

SPAT

Psychiatric/psychological examination

5.0

46.3

159

268

ZX120

NOMESCO Finland

Intravenous

3.9

46.1

208

459

F43.1

ICD-10 Finland

Post-traumatic stress disorder

7.8

45.8

112

120

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

59.3

45.8

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.0

45.8

649

2836

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.6

45.6

361

1188

H36.01

ICD-10 Finland

Diabetic maculopathy

207.6

45.3

201

Kela drug reimbursment

Chronic cardiac insufficiency

44.6

45.2

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

18.2

45.1

H01AC01

ATC

somatropin; parenteral

13.0

45.0

L17

ICPC

Foot/toe symptom/complaint

2.0

44.8

690

3114

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

44.8

2909

20019

C01DA14

ATC

isosorbide mononitrate; oral

88.1

44.8

4CJ01

NOMESCO Finland

+∞

44.4

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

+∞

44.4

A10AA03

ATC

+∞

44.4

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

25.0

44.4

J01MA12

ATC

levofloxacin; systemic

2.6

44.4

351

1155

L03AA02

ATC

filgrastim; parenteral

203.3

44.3

L28

ICPC

Limited function/disability (L)

3.6

44.3

219

522

ZXA10

NOMESCO Finland

Bilateral

2.4

44.2

428

1571

TPX10

NOMESCO Finland

Implantation of vascular injection port

14.8

44.1

L03

ICPC

Low back symptom/complaint

1.9

44.0

723

3341

M04AA01

ATC

allopurinol; systemic

4.6

43.9

165

306

TFP34

NOMESCO Finland

Electrophysiological investigation

86.4

43.9

E23.05

ICD-10 Finland

Lack of TSH

388.4

43.8

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

3.0

43.6

274

781

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

11.2

43.5

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

+∞

43.5

A10AB06

ATC

insulin glulisine; parenteral

+∞

43.5

N02AJ06

ATC

codeine and paracetamol; systemic

1.7

43.4

1194

6533

E66

ICD-10 Finland

Obesity

5.3

43.3

142

227

XF600

NOMESCO Finland

Bloodpressure measurement

4.4

43.1

169

327

SPAT1312

SPAT

General health counselling

1.7

43.1

1322

7461

M25.5

ICD-10 Finland

Pain in joint

1.8

42.9

825

4030

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

+∞

42.5

A04AA02

ATC

granisetron; systemic, transdermal

194.9

42.4

C02AC05

ATC

moxonidine; oral

28.2

42.4

XX3DW

NOMESCO Finland

Time consuming IT work

4.9

42.3

149

258

Z94.0

ICD-10 Finland

Kidney transplant status

49.8

42.2

N05AA01

ATC

chlorpromazine; systemic, rectal

132.7

42.2

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

15.1

42.1

C08CA02

ATC

felodipine; oral

12.1

42.0

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.3

41.9

228

586

SPAT1252

SPAT

Overall medication plan or its review

6.9

41.8

111

135

SPAT1216

SPAT

Assessment of functional ability

3.3

41.6

232

606

C07AG02

ATC

carvedilol; oral

20.8

41.5

N05AL01

ATC

sulpiride; systemic

190.7

41.5

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

4.3

41.5

167

332

M54.5

ICD-10 Finland

Low back pain

1.7

41.4

1000

5250

XW000

NOMESCO Finland

Bone marrow biopsy

11.7

41.3

G44.2

ICD-10 Finland

Tension-type headache

2.5

41.3

368

1294

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

12.2

41.2

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

16.2

41.0

L04AA06

ATC

mycophenolic acid; systemic

16.2

41.0

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.9

40.7

723

3427

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

+∞

40.6

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

186.5

40.5

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

5.0

40.1

137

230

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

10.9

39.6

SPAT1153

SPAT

Removal of sutures

1.9

39.6

667

3098

A10BH05

ATC

linagliptin; oral

+∞

39.6

E03.1

ICD-10 Finland

Congenital hypothyroidism without goitre

+∞

39.6

I50.1

ICD-10 Finland

Left ventricular failure

+∞

39.6

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

+∞

39.6

F41.8

ICD-10 Finland

Other specified anxiety disorders

6.1

39.5

115

159

IGV01

NOMESCO Finland

Psychiatric network contact

124.4

39.4

WF002

NOMESCO Finland

Radical radiotherapy

29.1

39.3

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

78.0

39.2

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

39.2

1816

11320

JN3AD

NOMESCO Finland

Abdominal CT examination

4.2

39.1

159

319

J45.9

ICD-10 Finland

Asthma, unspecified

2.2

39.0

441

1741

XCK00

NOMESCO Finland

Perimetry

4.8

38.8

138

242

P15

ICPC

Chronic alcohol abuse

6.3

38.8

110

147

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

6.8

38.7

103

126

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

16.2

38.7

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

+∞

38.6

I20.09

ICD-10 Finland

Unstable angina

+∞

38.6

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

50.8

38.5

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

121.6

38.4

WX290

NOMESCO Finland

Other blockade of nerve

1.5

38.1

2074

13392

UKC02

NOMESCO Finland

Cystoscopy

3.2

38.1

221

595

N18.8

ICD-10 Finland

Other chronic renal failure

26.9

37.8

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.8

37.7

724

3514

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

37.7

1170

6570

M01AE02

ATC

naproxen; oral, rectal

1.5

37.7

2091

13546

B01AC24

ATC

ticagrelor; oral

+∞

37.7

160

Kela drug reimbursment

exenatide

+∞

37.7

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

20.4

37.5

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

118.8

37.5

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

118.8

37.5

B03XA02

ATC

darbepoetin alfa; parenteral

91.2

37.4

N06AA06

ATC

trimipramine; systemic

17.2

37.2

C09BA02

ATC

enalapril and diuretics; systemic

9.5

37.0

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

27.5

36.7

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

+∞

36.7

I25.2

ICD-10 Finland

Old myocardial infarction

+∞

36.7

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

+∞

36.7

A10BJ02

ATC

liraglutide; parenteral

+∞

36.7

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

+∞

36.7

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

36.7

1995

12837

IBA03

NOMESCO Finland

Psychotherapy evaluation

54.4

36.6

C73.92

ICD-10 Finland

Follicular carcinoma of the thyroid gland

116.0

36.6

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

116.0

36.6

R55

ICD-10 Finland

Syncope and collapse

2.9

36.5

236

682

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.5

36.5

2173

14260

A12AA04

ATC

calcium carbonate; oral

62.2

36.5

J02AC01

ATC

fluconazole; systemic

1.8

36.5

728

3577

Z49.1

ICD-10 Finland

Extracorporeal dialysis

89.1

36.5

C03AA03

ATC

hydrochlorothiazide; oral

14.2

36.3

XKD00

NOMESCO Finland

Uroflowmetry

3.2

36.2

204

538

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

321.2

36.1

N05BA02

ATC

chlordiazepoxide; systemic

17.2

36.1

R02

ICPC

Shortness of breath/dyspnoea

2.6

36.0

285

935

K85

ICPC

Elevated blood pressure

3.7

36.0

168

382

F42.2

ICD-10 Finland

Mixed obsessional thoughts and acts

43.3

36.0

A02BC03

ATC

lansoprazole; oral

2.0

35.9

497

2135

N03AF01

ATC

carbamazepine; oral, rectal

5.9

35.8

106

150

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.3

35.7

377

1438

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

+∞

35.7

A10BG03

ATC

pioglitazone; oral

+∞

35.7

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

+∞

35.7

I20.99

ICD-10 Finland

Angina pectoris, unspecified

+∞

35.7

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

71.3

35.5

J01MA02

ATC

ciprofloxacin; systemic

1.7

35.5

854

4445

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.8

35.2

657

3152

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

2.3

35.2

357

1338

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

10.1

34.9

N05AF01

ATC

flupentixol; systemic

46.6

34.9

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

12.9

34.9

IEY01

NOMESCO Finland

Psychoeducation, individual

110.4

34.7

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

59.5

34.7

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

5.5

34.6

109

167

F10.25

ICD-10 Finland

Alcohol dependence continuous use

13.0

34.5

R60.0

ICD-10 Finland

Localized oedema

3.6

34.4

164

380

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

3.4

34.4

181

454

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.6

34.3

276

915

N03AF02

ATC

oxcarbazepine; oral

4.9

34.3

120

207

ZXA00

NOMESCO Finland

Right side

2.0

34.3

514

2277

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

4.0

34.2

147

311

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

17.9

34.2

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

32.5

33.9

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

4.4

33.9

130

247

I42.0

ICD-10 Finland

Dilated cardiomyopathy

+∞

33.8

N05AF05

ATC

zuclopenthixol; systemic

+∞

33.8

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

+∞

33.8

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

58.1

33.8

N06AX18

ATC

reboxetine; oral

107.6

33.7

R00.0

ICD-10 Finland

Tachycardia, unspecified

4.8

33.7

120

211

E29.1

ICD-10 Finland

Testicular hypofunction

5.1

33.6

112

183

SPAT1139

SPAT

Nutrition survey

5.5

33.5

105

160

SPAT1281

SPAT

Other administrative function

2.7

33.4

251

800

SPAT1283

SPAT

Restricted health certificate

1.6

33.3

1007

5578

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

4.0

33.3

142

299

D11

ICPC

Diarrhoea

2.0

33.1

451

1924

F50.9

ICD-10 Finland

Eating disorder, unspecified

8.3

33.1

102

Kela drug reimbursment

Diabetes insipidus

153.1

33.0

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

13.0

32.9

E03.0

ICD-10 Finland

Congenital hypothyroidism with diffuse goitre

+∞

32.8

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

+∞

32.8

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

+∞

32.8

E03.2

ICD-10 Finland

Hypothyroidism due to medicaments and other exogenous substances

+∞

32.8

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

80.7

32.8

EBA00

NOMESCO Finland

Extraction of tooth

1.6

32.7

1330

7933

N06AA04

ATC

clomipramine; systemic

27.8

32.7

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.3

32.5

327

1218

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

5.9

32.5

136

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

14.2

32.5

R00.2

ICD-10 Finland

Palpitations

3.2

32.4

182

479

F32.8

ICD-10 Finland

Other depressive episodes

18.8

32.3

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

287.7

32.3

F42.0

ICD-10 Finland

Predominantly obsessional thoughts or ruminations

31.1

32.2

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

4.4

32.2

124

237

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

3.2

31.9

178

464

G04CA02

ATC

tamsulosin; oral

2.3

31.9

308

1125

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

102.1

31.9

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

+∞

31.9

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

+∞

31.9

PHM76

NOMESCO Finland

Endovenous obliteration of v.saphena magna

+∞

31.9

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

6.8

31.6

103

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

3.2

31.6

177

465

X78

ICD-10 Finland

Intentional self-harm by sharp object

38.6

31.5

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

13.0

31.3

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

10.2

31.3

ZXA05

NOMESCO Finland

Left side

2.0

31.3

474

2105

Z01.7

ICD-10 Finland

Laboratory examination

2.2

31.1

339

1311

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

3.3

31.1

168

430

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.0

31.1

194

550

J01DA01

ATC

[U] cefalexin; systemic

1.5

31.1

1955

12797

E89.2

ICD-10 Finland

Postprocedural hypoparathyroidism

144.7

31.1

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

+∞

30.9

C01BD01

ATC

amiodarone; systemic

+∞

30.9

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

+∞

30.9

F22.0

ICD-10 Finland

Delusional disorder

+∞

30.9

BA1NN

NOMESCO Finland

I-131 dose capsel measurement

+∞

30.9

E0000UV

ATC

1.5

30.8

1309

7865

B01AF02

ATC

apixaban; oral

23.8

30.8

B03BA03

ATC

hydroxocobalamin; parenteral

12.0

30.7

J01CA04

ATC

amoxicillin; systemic

1.6

30.7

3306

24249

WX882

NOMESCO Finland

High dependency care

6.6

30.6

105

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

14.5

30.5

AAE10

NOMESCO Finland

Transsphenoidal total or partial excision of intracranial lesion

24.9

30.5

SPAT1215

SPAT

Assessment of need for medical rehabilitation

4.8

30.3

107

187

F10.24

ICD-10 Finland

Alcohol depence active use

14.0

30.1

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

2.3

30.1

303

1127

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

61.3

30.0

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.8

30.0

208

631

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

23.3

29.9

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

+∞

29.9

188

Kela drug reimbursment

Psychosis requiring demanding treatment

+∞

29.9

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

+∞

29.9

121

Kela drug reimbursment

Severe hypofunction of sexual glands

9.9

29.9

WX780

NOMESCO Finland

Remote monitoring CPAP

3.8

29.8

136

304

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

13.6

29.8

C10AB05

ATC

fenofibrate; oral

11.5

29.6

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.8

29.6

534

2523

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

19.5

29.6

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

5.9

29.6

123

A10BB12

ATC

glimepiride; oral

262.5

29.4

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

7.2

29.4

T99

ICPC

Endocr/metab/nutrit disease other

13.2

29.4

K86

ICPC

Hypertension uncomplicated

5.9

29.4

124

SPAT1053

SPAT

Memory test

13.7

29.4

R01AD09

ATC

mometasone; nasal

1.5

29.2

1453

9011

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

10.4

29.2

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.5

29.2

1187

7041

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

136.4

29.2

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

136.4

29.2

S97

ICPC

Chronic ulcer skin

6.8

29.2

R74

ICPC

Upper respiratory infection acute

1.5

29.1

1268

7641

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

+∞

29.0

E10.01

ICD-10 Finland

Insulin-dependent diabetes diabetic coma with hyperglycemia

+∞

29.0

C81.1

ICD-10 Finland

Nodular sclerosis classical Hodgkin lymphoma

+∞

29.0

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

4.9

28.9

100

171

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

28.9

678

3482

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

397

143

16.28

321.93

5.7

2.3

u/ml

0.3

0.29

228

(3005719) IgG [Mass/volume] in Serum or Plasma

1686

3313

3.12

321.18

2.8

2.2

g/l

10.6

10.9

1.39

1530

3049

(3004119) Hemoglobin [Mass/volume] in Venous blood

910

1121

4.85

320.22

4.3

2.0

g/l

131.3

139.8

17.90

883

1107

(3042936) Bacteria identified in Isolate by Culture

2318

5470

2.64

320.02

2.2

1.5

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

1883

3966

2.92

319.59

2.0

1.4

mu/l

332.8

269.7

7.49

1667

3618

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

7169

26780

1.88

318.33

3.6

2.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1671

3290

3.11

317.17

3.1

1.7

—

(3002385) Erythrocyte distribution width [Ratio]

14614

68715

2.04

315.56

16.8

6.1

13.5

13.3

19.17

14349

66984

(3007853) Bacteria identified in Skin by Aerobe culture

2277

5418

2.61

308.71

1.8

1.4

—

(3002032) Base excess in Venous blood by calculation

1443

1837

4.81

307.65

4.8

2.4

mmol/l

1.7

1.9

1.28

1149

1491

(3020682) Albumin/Creatinine [Ratio] in Urine

4811

5725

6.16

307.65

4.7

2.1

mg/mmol

10.3

15.6

0.85

3195

3165

(3033658) Prothrombin time (PT) actual/Normal

4106

10333

2.65

307.65

4.1

2.2

96.3

97.3

1.51

3957

10027

(3006504) Eosinophils/100 leukocytes in Blood

8633

27429

2.51

307.65

6.5

4.7

2.9

0.44

8063

25779

(3000850) Epithelial cells [#/volume] in Urine

3482

8670

2.61

307.65

2.6

1.8

e6/l

6.8

6.5

0.32

3079

7336

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

5701

13090

3.17

307.65

3.3

1.5

ng/l

40.1

15.4

4.14

2991

4542

(3031040) Bacteria [#/volume] in Urine by Automated count

11266

42454

2.33

307.65

4.3

2.8

e6/l

1015.9

1306.2

0.36

167

427

(3027801) Oxygen [Partial pressure] in Arterial blood

1587

1910

5.13

307.65

9.0

5.4

kpa

12.6

14.3

16.86

1517

1827

(3019309) Folate [Moles/volume] in Red Blood Cells

3069

3849

5.29

307.65

1.8

1.5

nmol/l

1190.1

1143.3

1.54

2439

2842

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

8779

16087

5.05

307.65

8.0

3.1

mmol/l

1.2

36.26

7305

13815

(3009261) Glucose [Presence] in Urine by Test strip

8999

33786

2.03

307.65

3.6

2.4

estimate

0.0

0.96

2019

5856

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

12435

55124

1.89

307.65

3.5

2.0

u/l

44.0

31.2

58.23

11841

53078

(3035350) Ketones [Presence] in Urine by Test strip

8942

33310

2.04

307.65

3.5

2.4

estimate

0.0

1.08

2043

5648

(3022217) INR in Platelet poor plasma by Coagulation assay

1476

2447

3.68

307.65

16.4

2.2

inr

1.1

1.0

4.34

229

495

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

899

979

5.49

307.65

3.4

1.4

ng/l

122.7

62.2

1.83

798

854

(3013512) EKG study

4380

9488

3.16

307.65

3.4

1.7

—

(3021960) Folate [Moles/volume] in Serum or Plasma

3763

6677

3.81

307.65

1.5

1.2

nmol/l

19.9

21.3

5.97

3335

5766

(3036481) Cortisol [Moles/volume] in Serum or Plasma

3133

2768

7.62

307.65

2.7

1.7

nmol/l

369.9

382.6

1.91

2869

2589

(3032080) INR in Blood by Coagulation assay

5714

11535

3.66

307.65

7.0

2.0

inr

1.1

1.50

1976

3911

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

15577

74464

2.24

307.65

4.1

2.5

mmol/l

1.4

1.2

141.92

14686

71228

(3013707) Erythrocyte sedimentation rate by Westergren method

13349

47459

3.18

307.65

4.2

2.9

mm/h

9.9

7.6

89.23

12503

44506

(3012544) pH of Venous blood

1477

1910

4.74

307.65

4.9

2.3

7.4

—

(3003396) Base excess in Arterial blood by calculation

1604

1908

5.19

307.65

9.0

5.3

mmol/l

0.8

0.06

1232

1383

(3026782) Osmolality of Urine

3285

7700

2.76

307.65

2.8

1.8

mosm/kgh2o

541.7

579.9

12.99

2836

6367

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2949

3331

5.86

307.65

3.9

2.1

mmol/l

0.8

19.75

2761

3099

(3027945) Reticulocytes/100 erythrocytes in Blood

1655

2336

4.37

307.65

3.0

1.9

1.8

1.5

22.63

1477

2080

(4035726)

1327

1824

4.42

307.65

1.4

1.2

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1328

1541

5.25

307.65

9.9

6.0

g/l

124.7

127.7

3.56

1284

1469

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

15069

61191

3.19

307.65

5.9

2.3

mmol/mol

39.4

35.6

307.65

14235

58010

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

4021

6962

3.96

307.65

1.7

1.3

pmol/l

32143284.9

48302621.6

0.72

3444

6155

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

473

231

12.04

307.65

3.1

2.0

nmol/l

0.9

0.8

1.41

370

214

(3009214) Lutropin [Units/volume] in Serum or Plasma

1543

2672

3.53

307.65

1.5

1.3

u/l

8.3

7.9

0.44

1255

2249

(3013115) Eosinophils [#/volume] in Blood

9654

30260

2.73

307.65

6.7

4.6

e9/l

0.2

4.86

8727

27342

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

4928

9693

3.61

307.65

2.3

1.6

u/l

189.9

205.2

0.34

4659

9172

(42870588) Differential panel, method unspecified - Blood

6205

16422

2.76

307.65

6.3

5.2

—

(3009508) Creatinine [Moles/volume] in Urine

5457

7780

5.29

307.65

3.8

1.9

mmol/l

8.1

8.9

16.25

4750

6829

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

8259

29486

2.10

307.65

4.2

3.3

—

(3002582) Erythrocytes [#/volume] in Urine

4784

13455

2.40

307.65

3.2

2.1

e6/l

79.3

70.3

0.13

3737

9580

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2293

3866

3.75

307.65

2.8

1.5

29.9

28.7

14.29

2221

3743

(3035637) Corticotropin [Mass/volume] in Plasma

556

294

11.17

307.65

1.8

1.4

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

17540

83130

4.75

307.65

15.3

4.9

umol/l

73.4

71.0

19.24

17535

83042

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

6866

14211

3.82

307.65

1.9

1.4

pmol/l

98.2

100.3

2.44

3947

7311

(3020630) Protein [Mass/volume] in Serum or Plasma

1138

1606

4.27

307.65

2.7

1.4

g/l

66.5

68.5

12.14

1062

1497

(3037522) Nuclear Ab [Titer] in Serum

3217

8062

2.56

307.65

1.4

1.3

titre

551.5

581.3

0.32

703

1510

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

4566

13492

2.25

307.65

1.8

1.4

mmol/l

1.5

1.2

42.70

3840

12023

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1080

1413

4.60

307.65

8.0

5.9

mmol/l

24.5

24.7

0.61

1070

1408

(3019060) Gas panel - Arterial blood

906

976

5.55

307.65

6.1

3.1

—

(3016502) Oxygen saturation in Arterial blood

1437

1620

5.44

307.65

9.6

5.8

96.0

96.6

1.55

1383

1550

(3021601) Nitrite [Presence] in Urine by Test strip

8934

33468

2.03

307.65

4.7

3.4

estimate

0.0

1.23

2108

5899

(3018010) Neutrophils/100 leukocytes in Blood

8904

29031

2.46

307.65

6.3

4.5

55.9

55.3

4.64

8382

27592

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1581

2277

4.27

307.65

2.6

2.1

g/l

0.2

5.71

1476

2148

(3030467) Casts [#/volume] in Urine by Automated count

4334

11906

2.42

307.65

3.1

2.1

e6/l

0.3

0.46

3327

8265

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

13197

40601

3.99

307.65

7.7

3.9

u/l

74.7

70.9

24.21

12502

37835

(3023520) Reticulocytes [#/volume] in Blood

1195

1445

5.01

307.65

2.8

1.8

e9/l

73.6

66.3

7.14

916

1043

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1082

1251

5.21

307.65

2.3

1.3

ug/l

7.7

3.4

5.75

963

1089

(3001122) Ferritin [Mass/volume] in Serum or Plasma

10251

31349

2.96

307.65

3.5

2.2

ug/l

91.8

70.8

24.42

9659

29963

(3009343) pH of Capillary blood

1125

1457

4.66

307.65

4.0

2.8

7.4

3.59

164

122

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

571

393

8.58

307.65

2.7

2.6

nmol/l

19.6

21.6

2.59

542

388

(3019225) pH of Specimen

1685

3071

3.37

307.65

4.7

2.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2873

5198

3.57

307.65

2.8

1.6

mmol/l

2.4

1.33

2528

4467

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1774

2499

4.40

307.65

4.9

2.4

u/l

228.1

219.1

2.49

1686

2376

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

8775

21186

3.61

307.65

6.0

2.6

umol/l

10.1

11.3

12.43

8225

19754

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1729

1557

6.93

307.65

4.1

2.6

ng/l

74.4

65.6

1.91

1542

1400

(3023103) Potassium [Moles/volume] in Serum or Plasma

17039

70184

5.72

307.65

14.8

4.2

mmol/l

3.9

0.05

16591

67240

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

5008

9334

3.85

307.65

2.3

1.8

mg/l

2.7

2.4

22.20

4298

7957

(40760892) CBC W Ordered Manual Differential panel - Blood

4998

15660

2.14

307.65

4.5

3.1

—

(3028707) Methadone [Presence] in Urine by Screen method

719

516

8.29

307.65

2.9

1.8

—

(3021589) Normoblasts [#/volume] in Blood

8319

26780

2.42

307.65

10.0

5.4

e9/l

0.0

0.28

7023

22262

(3019069) Monocytes/100 leukocytes in Blood

8684

27608

2.51

307.65

6.9

4.8

8.2

8.1

2.29

8167

26174

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1646

1951

5.22

307.65

4.1

1.7

mmol/l

1.2

7.36

1424

1648

(3000991) Gas panel - Venous blood

1323

1624

4.96

307.65

10.1

5.8

—

(3044889) 12 lead EKG panel

11244

36748

2.92

307.65

3.4

1.8

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

16999

69715

5.68

307.65

14.7

4.2

mmol/l

139.5

139.8

40.85

16585

67003

(3044640) Blood type and Crossmatch panel - Blood

5549

16542

2.32

307.65

2.3

1.5

—

(40758558) Short blood count panel - Blood

4537

12011

2.55

307.65

7.2

3.9

—

(3026008) Bacteria identified in Urine by Culture

4617

13547

2.27

307.65

2.5

1.9

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1336

1743

4.67

307.65

8.6

5.0

mmol/l

1.3

0.20

1281

1679

(3024561) Albumin [Mass/volume] in Serum or Plasma

7136

15206

3.75

307.65

5.2

3.0

g/l

36.6

37.7

50.67

6660

14083

(3002030) Lymphocytes/100 leukocytes in Blood

9034

29399

2.49

307.65

6.5

4.5

29.7

31.0

23.34

8473

27765

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1587

1911

5.12

307.65

9.0

5.4

kpa

5.1

5.0

2.71

1516

1827

(3020779) Urea [Moles/volume] in Serum or Plasma

1446

1437

6.18

307.65

10.3

3.8

mmol/l

8.3

6.3

21.10

1383

1375

(36304419) Bacteria [Presence] in Urine

4327

12274

2.34

307.65

3.0

2.0

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

7940

13965

4.96

307.65

7.2

2.9

mmol/l

1.2

27.70

7282

12421

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

4792

4307

8.26

307.65

1.3

1.2

iu/ml

209.8

112.3

30.30

2202

1614

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

18073

50830

38.28

307.65

10.2

2.1

pmol/l

15.2

14.2

307.65

17470

46577

(3008152) Bicarbonate [Moles/volume] in Arterial blood

906

1035

5.24

307.65

8.3

4.1

mmol/l

24.3

0.06

848

942

(3006315) Basophils [#/volume] in Blood

9347

28929

2.72

307.65

6.5

4.7

e9/l

0.0

1.79

8327

25800

(3014576) Chloride [Moles/volume] in Serum or Plasma

1817

2492

4.53

307.65

8.6

4.5

mmol/l

104.5

105.1

4.80

1783

2446

(3024354) Oxygen [Partial pressure] in Venous blood

1166

1585

4.44

307.65

4.4

2.3

kpa

4.8

0.23

1124

1543

(40761511) CBC panel - Blood by Automated count

17657

86590

4.41

307.65

13.7

4.9

—

(3022948) Iron [Moles/volume] in Serum or Plasma

3129

4496

4.60

307.65

2.6

1.5

umol/l

14.4

21.0

0.83

2883

4190

(3037467) Urinalysis macro (dipstick) panel - Urine

11878

46488

2.30

307.65

4.3

2.9

—

(3007164) IgA [Mass/volume] in Serum or Plasma

4819

13244

2.47

307.65

1.5

1.3

g/l

2.2

2.1

1.88

3094

8942

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

5809

15740

2.63

307.65

1.4

1.2

u/ml

1.6

2.0

1.47

1835

4703

(3023368) Bacteria identified in Blood by Culture

3762

7903

3.17

307.65

4.4

2.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2362

4898

3.03

307.65

1.9

1.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

450

119

22.24

307.65

2.6

2.1

ug/min

141.7

72.8

0.85

307

(3013650) Neutrophils [#/volume] in Blood by Automated count

10483

32454

2.96

307.65

9.8

4.8

e9/l

4.0

3.9

1.73

9390

28556

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2444

2706

5.82

307.65

7.0

3.5

mmol/l

1.1

1.0

2.76

2282

2522

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

5810

14021

3.01

307.65

3.0

1.7

u/l

55.5

59.3

2.14

5378

13037

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

15769

67739

3.22

307.65

11.9

4.1

ml/min/173m2

91.2

92.1

5.28

13230

52324

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

16295

78689

2.53

307.65

4.9

2.7

mmol/l

2.8

3.1

183.21

15377

74600

(3022096) Basophils/100 leukocytes in Blood

8351

26326

2.49

307.65

6.6

4.8

0.7

0.44

7809

24770

(40768797) Stomach Pathology biopsy report

2504

5876

2.67

307.65

1.2

1.1

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

6158

11232

4.21

307.65

3.2

1.5

mmol/l

2.3

17.04

5578

9892

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1477

1180

7.73

307.65

2.3

2.1

iu/l

33.4

3.6

0.53

708

509

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

973

244

24.12

307.65

6.7

1.3

u/ml

79.4

152.6

0.50

393

(3018095) Leukocytes [#/volume] in Urine

5802

18213

2.21

307.65

3.7

2.4

e6/l

62.6

66.9

0.24

4071

10962

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

8548

21459

3.38

307.65

2.6

1.9

nmol/l

73.7

75.2

5.00

7956

20126

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3386

3937

5.82

307.65

3.2

1.3

ng/l

843.2

259.4

12.66

2696

2890

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2570

3356

4.94

307.65

2.8

1.6

24.2

27.1

14.27

2196

2923

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

4457

2094

15.77

307.65

4.4

3.2

pmol/l

4.5

4.8

18.11

4050

1930

(3018418) pH of Serum or Plasma

5420

8541

4.73

307.65

5.0

2.0

7.4

1.51

1198

1286

(3012516) Albumin [Mass/volume] in Urine

4600

5458

6.10

307.65

3.8

1.9

mg/l

483.1

705.9

1.15

3007

2938

(3001604) Monocytes [#/volume] in Blood

9300

28847

2.70

307.65

6.5

4.7

e9/l

0.6

0.5

14.37

8307

25759

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

739

107.79

307.65

8.2

2.0

—

(3019198) Lymphocytes [#/volume] in Blood

9664

30586

2.70

307.65

6.5

4.6

e9/l

2.0

0.70

8776

27794

(3013826) Glucose [Moles/volume] in Serum or Plasma

9957

26799

3.44

307.65

5.3

2.5

mmol/l

6.7

5.9

148.51

9153

22980

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1103

1404

4.73

307.65

4.0

2.8

mmol/l

1.2

0.03

793

988

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

16939

77677

3.84

307.65

13.9

5.3

mg/l

18.3

20.9

22.64

13801

53981

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1142

1477

4.67

307.65

4.0

2.8

kpa

5.1

0.02

1070

1376

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

16160

78292

2.42

307.65

4.5

2.7

mmol/l

4.7

5.0

241.59

15317

74823

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

907

960

5.65

307.65

11.1

7.7

0.7

0.92

902

955

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

15869

69779

3.09

307.65

4.5

2.4

mmol/l

5.9

5.4

292.59

14900

65532

(3029937) Albumin [Presence] in Urine by Test strip

5160

16866

2.05

307.65

3.9

2.5

estimate

0.0

0.24

2049

5808

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

18205

64389

30.92

307.65

11.6

2.4

mu/l

2.4

2.3

0.15

17536

60121

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

4245

10688

2.66

307.65

2.1

1.4

mg/l

1.0

0.8

2.18

3122

7718

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2824

3823

4.82

307.65

2.7

1.5

g/l

2.4

2.5

5.49

2583

3566

(3001019) Free T4 and TSH panel - Serum or Plasma

2769

5629

3.15

307.65

2.6

1.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

4155

12102

2.25

307.65

2.3

1.5

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

496

193

15.14

307.65

6.6

2.7

umol/l

393.1

391.0

0.06

437

157

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6474

17111

2.80

307.65

3.3

2.2

u/l

31.4

28.7

3.85

6156

16452

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

17631

85135

4.67

307.65

11.1

4.8

u/l

27.7

25.6

31.06

17194

82223

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

16061

77886

2.36

307.65

4.5

2.6

mmol/l

1.4

1.5

220.94

15177

74455

(3026493) Urate [Moles/volume] in Serum or Plasma

4523

12726

2.38

307.65

2.6

1.6

umol/l

2329.9

3482.3

1.58

4022

11545

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2551

5271

3.06

307.65

3.5

1.6

ng/l

325.2

287.2

0.16

1544

2396

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1451

1857

4.78

307.65

4.8

2.4

kpa

5.8

0.20

1397

1808

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2039

4595

2.74

306.26

2.7

1.9

umol/l

6.8

6.3

0.52

1740

3952

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

3747

11292

2.14

300.58

1.3

1.2

iu/ml

29.2

31.7

0.13

1104

3736

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

3571

10635

2.15

294.37

1.3

1.2

u/ml

9.8

11.3

0.64

1554

4689

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1521

2969

3.12

291.90

1.8

1.3

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1497

2901

3.14

290.61

1.7

1.3

—

(40768804) Tissue Pathology biopsy report

6861

25914

1.83

286.14

2.0

1.6

—

(3010421) pH of Blood

572

482

7.00

285.34

3.7

1.9

7.4

2.51

485

394

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

3034

8563

2.24

283.81

1.9

1.4

1.2

71.16

2704

8011

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2014

4721

2.63

279.60

6.3

2.6

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

761

906

4.99

277.15

12.2

6.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

473

323

8.61

274.84

1.2

1.1

iu/ml

1980.4

9.0

0.54

140

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

809

1047

4.60

269.14

5.2

2.4

mmol/l

24.0

24.4

2.98

733

947

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

557

493

6.66

266.98

2.9

1.7

—

(3004588) Protein electrophoresis panel - Serum or Plasma

874

1227

4.24

264.56

2.3

1.3

—

(3017181) Myelocytes/100 leukocytes in Blood

1647

3570

2.81

263.77

4.4

3.7

0.9

0.5

5.40

402

502

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1175

2078

3.40

261.67

1.6

1.4

—

(3007461) Platelets [#/volume] in Blood

18333

97539

6.71

261.23

22.0

7.4

e9/l

262.3

257.1

23.10

18093

94645

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

716

852

4.98

260.75

11.9

7.9

mmol/l

24.2

24.3

0.45

680

810

(1616796) Gas panel - Central venous blood

491

392

7.36

255.23

3.5

2.0

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1290

2465

3.16

255.13

1.8

1.6

g/l

1.2

1.3

0.93

1183

2304

(3027315) Oxygen [Partial pressure] in Blood

495

401

7.26

254.46

3.8

1.9

kpa

9.0

9.2

1.75

487

395

(3027273) Bicarbonate [Moles/volume] in Venous blood

715

871

4.86

253.96

4.0

2.2

mmol/l

25.0

25.4

2.08

682

836

(3022313) Gas panel - Capillary blood

810

1104

4.36

253.80

3.9

2.9

—

(3035941) MCH [Entitic mass]

18336

97771

6.60

252.78

21.8

7.4

30.1

0.18

18201

96391

(3013290) Carbon dioxide [Partial pressure] in Blood

492

400

7.23

252.22

3.8

1.9

kpa

5.0

4.9

1.24

484

394

(3012501) Base excess in Blood by calculation

492

400

7.23

252.22

3.8

1.9

mmol/l

2.2

1.8

2.16

315

223

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

280

21.76

251.65

1.5

1.2

pmol/l

14.5

13.7

0.77

236

(3024731) MCV [Entitic volume]

18334

97790

6.53

251.18

21.9

7.4

90.1

89.8

25.37

18200

96397

(3026361) Erythrocytes [#/volume] in Blood

18336

97818

6.56

250.83

21.9

7.4

e12/l

4.6

51.95

18067

94756

(3010813) Leukocytes [#/volume] in Blood

18338

97878

6.57

249.15

22.0

7.4

e9/l

6.7

6.5

46.25

18068

94776

(3000963) Hemoglobin [Mass/volume] in Blood

18338

97921

6.53

247.36

22.1

7.4

g/l

136.4

138.5

87.61

18204

96544

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

663

773

5.07

246.49

1.3

1.2

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

662

781

5.01

243.10

2.1

1.7

g/l

1.4

1.1

7.96

567

673

(3002179) Metamyelocytes/100 leukocytes in Blood

1523

3325

2.78

239.96

4.1

3.5

0.7

0.3

5.10

291

380

(3023183) Ammonium ion [Moles/volume] in Plasma

419

293

8.38

239.49

3.4

2.9

umol/l

35.1

34.7

0.07

359

248

(3021440) Promyelocytes/100 leukocytes in Blood

1571

3500

2.72

238.47

4.5

3.8

0.1

0.0

0.68

368

476

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

673

824

4.83

237.62

3.9

1.8

0.7

0.15

652

772

(3020891) Body temperature

601

668

5.31

234.38

5.8

2.8

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1940

4855

2.45

234.06

3.1

1.8

nmol/l

11.3

13.9

29.48

1745

4548

(3018405) Lactate [Moles/volume] in Arterial blood

527

520

5.96

229.91

4.7

2.7

mmol/l

1.3

0.23

519

515

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1051

1896

3.32

226.57

3.7

2.0

ug/l

24.4

7.9

0.79

798

1244

(3023323) Follitropin [Units/volume] in Serum or Plasma

1931

4920

2.40

223.78

1.4

1.2

iu/l

20.8

25.6

7.76

1634

4337

(3025159) Blasts/100 leukocytes in Blood

1503

3390

2.68

222.43

4.5

3.8

0.1

0.0

0.60

315

413

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2479

7069

2.17

221.84

2.6

1.9

e6/l

1.0

0.9

1.28

1404

3756

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

650

824

4.66

220.85

4.8

2.3

52.3

47.0

3.92

639

818

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

573

646

5.23

220.24

2.6

2.0

ug/l

449.4

421.9

0.08

522

574

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

527

554

5.60

216.81

2.3

1.6

ug/l

1.8

1.7

0.13

474

479

(40761536) Microorganisms panel - Urine sediment

1972

5155

2.34

215.70

3.5

2.3

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1592

3762

2.57

215.09

2.5

1.8

u/l

35.4

43.4

1.75

1367

3252

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

257

+∞

213.70

17.4

0.0

nmol/l

1380.5

—

245

(3011985) Renin [Units/volume] in Plasma

368

263

8.18

207.14

2.4

1.6

mu/l

77.8

49.5

1.20

335

248

(3048689) Calprotectin [Mass/mass] in Stool

2952

9233

1.99

206.50

2.2

2.8

ug/g

125.5

118.9

0.38

2307

7473

(3019150) Specific gravity of Urine by Refractometry

3874

13309

1.85

205.46

3.9

2.5

kg/l

1.0

1.36

517

2235

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

247

+∞

205.36

12.7

0.0

nmol/l

772.1

—

236

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2332

6687

2.15

204.70

2.9

1.9

e6/l

3.6

3.3

0.48

1256

3401

(3041096) Erythrocytes [Presence] in Urine by Automated

5327

20195

1.72

202.88

3.1

2.1

—

(3043409) Potassium [Moles/volume] in Arterial blood

455

444

6.01

200.36

4.9

2.8

mmol/l

3.8

0.45

424

(3015235) Bicarbonate [Moles/volume] in Capillary blood

455

444

6.01

200.36

4.3

2.5

mmol/l

24.1

24.4

0.63

411

387

(40767503) Oxygen content in Capillary blood by calculation

419

375

6.54

198.76

2.8

1.5

17.0

18.5

6.76

216

164

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

707

1068

3.91

194.72

3.9

2.9

mmol/l

24.5

24.6

0.33

660

1018

(3000570) Elastase.pancreatic [Mass/mass] in Stool

568

719

4.65

193.13

1.4

1.3

ug/g

290.4

337.9

4.11

305

369

(3011397) Hemoglobin [Presence] in Urine by Test strip

3941

13846

1.81

192.95

3.6

2.5

—

(3036489) Thrombin time

764

1246

3.63

189.97

2.6

1.6

20.9

20.4

2.08

624

1024

(4146454)

190

32.43

189.42

3.4

1.3

—

(36660697) Celiac disease serology panel - Serum

1986

5507

2.20

188.26

1.2

1.1

—

(3008295) Osmolality of Serum or Plasma

277

154

10.47

182.51

1.9

1.5

mosm/kgh2o

286.2

285.6

0.12

228

123

(44816559) Phosphatidylethanol [Mass/volume] in Blood

557

732

4.48

181.52

1.4

1.2

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1028

2099

2.92

180.89

1.3

1.2

u/ml

0.8

0.7

0.20

134

(3021901) Oxygen saturation in Capillary blood

339

261

7.58

180.89

3.1

2.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

3167

10596

1.86

179.49

1.7

1.5

—

(40761535) Cells panel - Urine sediment

1344

3197

2.53

178.06

3.5

2.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

762

1313

3.43

175.13

1.6

1.2

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

200

19.03

172.27

1.3

nmol/l

1.5

1.7

0.64

172

(3003181) Sodium [Moles/volume] in Urine

282

178

9.23

172.25

1.9

1.6

mmol/l

71.6

76.3

0.41

227

145

(3002256) Pathology report gross observation

2152

6384

2.06

171.21

1.2

1.1

—

(3022145) Colonoscopy Study observation

1979

5705

2.11

169.46

1.3

1.4

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

669

1088

3.63

166.78

3.5

1.7

93.8

92.6

0.54

610

989

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

334

287

6.79

163.74

1.6

1.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

457

551

4.86

163.68

1.3

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

794

1473

3.19

163.15

1.7

1.4

nmol/l

0.5

0.49

656

1265

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

553

793

4.10

162.40

6.5

2.8

1.7

1.6

0.57

516

746

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

921

1883

2.90

161.37

2.1

2.0

u/l

39.4

40.8

1.25

848

1812

(3000494) Fungus identified in Specimen by Culture

2101

6325

2.02

160.07

1.5

1.3

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

538

766

4.13

159.37

6.8

2.8

0.9

0.49

502

723

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

745

1349

3.26

158.86

2.1

1.8

g/l

0.2

2.75

701

1285

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

761

1406

3.20

157.30

2.1

1.8

g/l

1.2

1.1

6.43

718

1343

(3011288) Drugs identified in Urine by Screen method

1005

2211

2.70

154.33

3.1

1.5

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

657

1142

3.39

148.85

1.8

1.5

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

922

1974

2.77

148.73

1.6

1.5

—

(3028271) Lactate [Moles/volume] in Capillary blood

311

276

6.57

148.50

2.2

1.4

mmol/l

1.7

1.6

0.64

306

271

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

668

1187

3.32

146.45

1.5

1.2

u/l

17.6

19.9

1.05

560

997

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

450

594

4.44

145.78

5.5

3.4

iu/ml

1178.8

691.4

0.25

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

297

255

6.78

145.69

1.5

1.2

pmol/l

416.0

293.2

2.14

229

193

(3009445) Proteinase 3 Ab [Units/volume] in Serum

780

1537

3.00

145.23

1.6

u/ml

9.5

11.4

0.27

(3028626) Oxygen [Partial pressure] in Capillary blood

453

606

4.38

144.50

4.2

3.9

kpa

9.0

9.2

1.81

427

570

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

606

1024

3.48

143.00

2.9

2.0

170.4

155.9

3.21

572

956

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

349

369

5.52

142.63

2.9

2.1

u/ml

657.8

46729.3

0.49

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1312

3424

2.29

141.61

2.8

1.5

ml/min/173m2

71.9

83.8

16.23

527

1032

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

589

985

3.51

141.04

4.7

2.9

mg/l

1.4

1.1

21.22

547

935

(3024928) Oxygen saturation in Venous blood

329

333

5.76

140.06

4.6

2.0

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

415

545

4.45

135.21

1.7

1.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

663

1246

3.13

133.21

1.3

titre

108.1

137.6

0.27

112

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1008

2402

2.49

132.09

1.1

u/ml

16.7

19.5

0.05

(3034770) Mitochondria Ab [Titer] in Serum

647

1206

3.16

131.68

1.3

titre

883.5

1332.1

0.59

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

732

1476

2.92

130.97

2.4

1.7

pmol/l

186.6

205.0

3.43

701

1433

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

776

1631

2.81

129.14

2.2

1.8

—

(3020961) Endomysium IgA Ab [Titer] in Serum

1378

3815

2.16

129.01

1.2

1.1

titre

85.5

207.7

2.55

130

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

308

320

5.61

127.97

1.4

1.2

nmol/l

0.2

0.1

0.37

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1923

6057

1.92

127.29

2.4

2.1

u/l

6582.6

6793.3

0.10

759

2845

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

309

327

5.50

126.17

1.4

1.2

nmol/l

3.9

4.0

0.01

298

313

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

339

396

4.99

125.46

3.8

1.6

mg/l

67.4

26.4

0.59

270

326

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

395

533

4.33

124.70

1.8

1.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

327

374

5.09

123.67

3.7

1.5

ratio

1.3

1.1

1.00

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

287

288

5.80

123.15

1.5

1.2

—

(3047181) Lactate [Moles/volume] in Blood

484

776

3.65

122.83

7.2

2.7

mmol/l

1.3

1.2

2.63

417

689

(3034860) Kappa light chains.free [Mass/volume] in Serum

337

400

4.91

122.66

3.8

1.6

mg/l

41.2

30.2

2.82

267

330

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

652

1282

2.99

121.63

1.8

1.6

titre

429.8

401.1

0.06

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

590

1091

3.18

121.52

2.1

mg/l

9.5

9.6

0.07

557

1054

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

508

856

3.48

120.25

1.9

1.4

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

196

126

9.02

118.36

1.8

3.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

281

289

5.66

117.88

1.4

1.2

nmol/l

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1910

6178

1.86

116.15

4.3

2.6

30.7

32.1

6.67

1457

4393

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

994

2536

2.32

112.24

2.1

1.6

nmol/l

39.0

42.8

3.65

973

2513

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

291

327

5.18

112.05

1.7

1.5

—

(3004775) Volume in Urine collected for unspecified duration

132

18.18

112.03

2.2

2.0

643.6

661.8

0.10

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

380

544

4.08

111.71

1.1

1.0

119.7

117.8

0.44

341

471

(40760888) Immunoglobulin light chains.free panel - Serum

270

283

5.55

111.27

3.8

1.6

—

(3039000) Anion gap in Blood

318

392

4.72

111.17

9.3

3.8

mmol/l

11.4

0.10

287

349

(3018572) Chloride [Moles/volume] in Blood

318

393

4.71

110.86

9.3

3.8

mmol/l

105.7

105.4

0.44

288

350

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2027

6815

1.80

108.58

1.5

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2743

10054

1.67

108.35

1.9

2.0

—

(4306422)

396

606

3.81

106.94

1.2

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

496

891

3.26

106.77

2.9

1.9

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

151

11.65

105.77

1.7

1.6

—

(4198724)

160

10.29

104.75

2.0

3.6

—

(3025941) Bacteria identified in Stool by Culture

1340

3976

2.01

104.12

1.3

1.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

593

1211

2.87

103.61

3.6

1.9

g/l

3.6

0.03

560

1145

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

697

1556

2.63

103.55

1.3

u/ml

21.6

38.5

1.11

101

(3027456) Digoxin [Moles/volume] in Serum or Plasma

107

28.10

103.31

3.1

2.8

nmol/l

0.8

1.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

439

746

3.44

102.62

2.3

1.2

g/l

7.2

6.9

1.95

338

579

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

438

746

3.43

102.05

2.3

1.2

g/l

3.7

0.23

319

532

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

431

726

3.47

102.03

2.7

2.6

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

438

747

3.43

101.85

2.3

1.2

—

(3017732) Neutrophils [#/volume] in Blood

1416

4332

1.95

100.92

2.7

1.7

e9/l

4.1

4.0

0.66

1187

3665

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

574

1168

2.88

100.90

1.3

1.2

mg/l

462.3

427.4

1.05

551

1117

(3003694) ABO and Rh group [Type] in Blood

5856

25763

1.45

100.58

1.7

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

302

389

4.52

100.58

1.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

394

634

3.63

99.46

1.3

1.2

u/ml

3.4

0.02

187

284

(1001926) Buprenorphine [Presence] in Urine by Screen method

1104

3096

2.11

99.35

2.4

1.3

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1481

4634

1.91

98.79

2.4

2.3

au/ml

21.7

20.6

0.14

505

(3016244) Insulin [Units/volume] in Serum or Plasma

293

374

4.56

98.58

2.8

3.5

mu/l

31.1

24.5

1.31

279

350

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

407

678

3.50

97.89

1.2

u/ml

4.2

3.8

0.09

143

238

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

186

147

7.33

97.37

9.1

4.5

mg/l

11.2

9.4

3.68

174

134

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

422

725

3.40

97.08

2.3

1.2

g/l

3.0

2.8

1.18

330

570

(3000034) Microalbumin [Mass/volume] in Urine

189

154

7.11

96.67

3.6

1.6

mg/l

42.3

60.7

0.41

146

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

399

663

3.51

96.30

1.1

1.0

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

520

1032

2.95

95.38

1.3

1.2

e6/l

26.9

10.1

0.95

412

795

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

520

1033

2.95

95.22

1.4

1.2

e6/l

1724.1

547.3

0.49

432

830

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1371

4243

1.92

94.28

1.3

au/ml

43.3

47.4

0.23

229

(3030981) Hyaline casts [#/volume] in Urine by Automated count

857

2212

2.28

94.00

3.1

1.8

e6/l

0.2

0.12

833

2117

(4010399)

1174

3446

2.02

93.64

1.4

1.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

376

617

3.55

92.37

2.4

1.3

g/l

0.4

0.3

0.47

343

551

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

165

119

8.03

92.32

1.6

1.4

nmol/l

4.9

1.6

1.41

141

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

397

679

3.41

91.93

2.4

1.2

g/l

9.8

10.3

1.51

342

580

(3037121) Protein [Mass/volume] in Urine

586

1273

2.70

91.57

3.6

3.0

g/l

0.5

0.3

0.84

269

505

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

510

1025

2.91

91.55

1.2

1.1

mmol/l

3.7

3.5

7.12

479

970

(46235355) HIV 1 and 2 tests - Meaningful Use set

5724

25410

1.42

91.54

2.1

1.9

—

(3005322) IgE [Units/volume] in Serum or Plasma

1524

4946

1.84

90.63

1.3

u/ml

222.1

241.3

0.11

1411

4630

(3004809) Band form neutrophils/100 leukocytes in Blood

264

334

4.59

89.73

3.1

2.0

1.6

1.5

0.03

215

245

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

585

1291

2.66

88.74

1.3

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

628

1445

2.55

87.85

1.4

1.3

u/ml

11.5

10.5

0.10

223

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

621

1429

2.55

86.86

1.4

1.3

u/ml

6.2

8.1

0.22

148

(1617658) Protocol used for examination of sentinel lymph nodes

20.74

86.10

1.1

1.0

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

135

9.76

85.77

2.8

1.4

umol/l

169.8

116.6

0.55

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

4808

20886

1.43

85.24

1.8

1.7

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

689

1683

2.40

85.23

2.1

1.7

—

(3037756) Immunofixation for Serum or Plasma

226

261

5.02

84.69

1.8

1.3

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

232

275

4.90

84.62

1.5

1.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

342

560

3.56

84.28

2.3

1.3

g/l

0.0

0.63

328

532

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

553

1218

2.66

84.18

1.3

1.2

u/ml

262.5

233.3

1.40

343

770

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

543

1185

2.68

84.10

1.5

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

216

241

5.20

83.83

1.5

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

562

1254

2.62

83.46

1.3

1.2

u/ml

44.1

41.2

0.13

106

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

314

487

3.75

83.33

1.4

1.2

umol/l

5.7

6.3

1.91

296

457

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

630

1500

2.46

82.21

1.9

1.7

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

289

425

3.95

82.18

1.5

1.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

386

699

3.22

82.06

2.5

1.9

g/l

132.2

136.4

2.82

305

528

(3013139) Helicobacter pylori Ag [Presence] in Stool

1284

4083

1.87

81.02

1.2

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

535

1182

2.65

80.95

1.5

1.2

u/ml

13.9

22.4

—

(3026250) Tacrolimus [Mass/volume] in Blood

115

11.46

79.96

41.0

29.2

ug/l

7.7

6.9

1.78

107

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

374

678

3.21

79.38

1.3

1.2

titre

46.7

54.5

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

245

325

4.38

78.95

1.5

1.4

72.2

72.4

0.04

230

311

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

5011

22185

1.41

78.67

1.8

1.6

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

250

340

4.27

78.25

1.4

1.1

u/l

20.4

14.0

0.68

225

294

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

445

907

2.86

77.95

1.3

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

408

794

3.00

77.31

1.6

g/l

0.6

0.8

1.95

295

624

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

240

319

4.37

77.17

1.5

1.4

mu/l

568.1

518.1

0.15

225

305

(3044290) Cell count panel - Cerebral spinal fluid

464

974

2.78

77.16

1.4

1.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

320

533

3.49

77.00

1.3

1.4

—

(3016879) Cocaine [Presence] in Urine

1285

4153

1.84

76.98

2.3

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

286

439

3.79

76.97

1.5

—

(3009542) Hematocrit [Volume Fraction] of Blood

15663

83557

1.49

76.61

14.8

5.6

40.3

41.0

24.41

12164

71935

(1002224) Polysomnography panel

1067

3256

1.94

75.98

1.1

1.0

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

469

1002

2.73

75.54

1.7

1.4

iu/ml

8.9

8.4

0.04

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

258

371

4.04

75.49

1.1

1.0

94.2

94.5

0.05

244

338

(3006653) Thiamine [Moles/volume] in Blood

151

127

6.88

75.40

1.4

1.2

nmol/l

132.5

132.2

0.02

151

127

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

729

1930

2.22

75.19

2.3

2.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

303

494

3.57

75.15

2.4

1.3

g/l

0.0

0.05

289

467

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

301

489

3.58

75.02

2.4

1.3

g/l

0.0

0.00

289

466

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

325

560

3.38

74.47

2.3

1.3

g/l

38.1

40.2

5.28

297

495

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

245

345

4.12

73.56

1.5

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

503

1132

2.60

73.45

1.5

1.2

u/ml

100.8

106.7

0.43

109

242

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

166

5.79

71.57

1.9

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

166

5.79

71.57

1.9

1.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

166

5.79

71.57

1.9

1.3

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

490

1106

2.59

71.14

1.3

1.2

u/ml

2.7

7.1

0.69

100

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

457

997

2.67

70.81

3.3

3.4

56.8

56.2

0.47

457

997

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

365

707

3.01

69.72

3.4

2.7

u/ml

282.7

82.9

0.75

308

608

(3030905) Polymorphonuclear cells [#/volume] in Blood

450

983

2.67

69.55

3.1

3.3

e9/l

3.9

3.8

0.54

450

983

(3048929) Epstein Barr virus Ab [Presence] in Serum

988

3031

1.92

69.15

1.3

1.2

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

472

1063

2.59

68.82

1.3

1.2

u/ml

8.4

15.2

—

(4268621)

279

457

3.55

68.77

2.3

2.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

201

254

4.58

68.48

1.2

u/l

56.9

63.1

0.55

138

161

(3016650) Hepatitis A virus Ab [Presence] in Serum

412

867

2.77

68.21

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

271

441

3.57

67.42

1.5

—

(3042517) Benzodiazepines panel - Urine

34.59

66.70

3.9

1.8

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

200

258

4.49

66.60

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

225

322

4.05

66.27

1.4

1.3

—

(3042733) HLA Ab [Presence] in Serum

11.94

64.68

5.0

3.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

206

280

4.26

64.58

1.8

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

188

236

4.61

64.55

3.9

1.9

—

(3000764) Benzodiazepines [Presence] in Urine

1353

4686

1.71

63.85

2.3

1.3

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

276

473

3.39

63.79

1.4

1.3

g/l

0.4

0.34

184

339

(3027135) IgG subclass 1 [Mass/volume] in Serum

276

474

3.38

63.60

1.4

1.3

g/l

7.2

6.6

1.32

183

337

(3028192) IgG subclass 2 [Mass/volume] in Serum

276

474

3.38

63.60

1.4

1.3

g/l

3.0

3.2

0.82

184

335

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

13.25

63.56

1.9

1.1

ug/min

177.7

4.1

1.44

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

225

336

3.88

62.82

3.6

2.5

u/ml

265.0

614.6

0.39

210

306

(3027008) Opiates [Presence] in Urine

1363

4752

1.70

62.77

2.3

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

190

247

4.45

62.74

1.5

1.3

—

(4062490)

274

474

3.36

62.47

1.4

1.3

—

(3028300) Cannabinoids [Presence] in Urine

1363

4759

1.70

62.42

2.3

1.3

—

(3023511) Choriogonadotropin [Units/volume] in Urine

906

2796

1.91

62.20

1.4

1.3

—

(3016038) Potassium [Moles/volume] in Urine

111

7.91

61.69

2.4

1.5

mmol/l

34.6

37.4

0.35

101

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

179

225

4.61

61.39

1.5

—

(3024471) HLA-A [Type]

10.82

60.78

1.0

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1122

3733

1.77

60.77

2.0

1.7

—

(40768795) Lymph node Pathology biopsy report

144

148

5.63

60.59

1.1

—

(3024932) HLA-DR beta [Type]

11.03

58.69

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

602

1640

2.15

57.86

1.2

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

792

2393

1.94

57.78

1.1

u/ml

5.2

6.0

0.19

114

432

(3003434) Protein [Mass/volume] in Pleural fluid

115

6.85

57.37

1.7

1.4

g/l

33.8

41.6

4.86

108

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

177

235

4.36

57.09

1.9

1.5

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

281

527

3.09

56.62

1.3

1.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

281

528

3.09

56.45

1.3

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

603

1662

2.12

56.29

1.2

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

218

347

3.64

55.98

7.2

1.6

mmol/l

7.7

5.8

8.11

190

269

(40768793) Breast Pathology biopsy report

332

692

2.79

55.96

1.3

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

3814

16909

1.37

55.90

2.2

1.9

—

(42529406) Shigella sp [Presence] in Stool by Culture

605

1675

2.11

55.84

1.2

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

370

821

2.62

55.55

1.1

1.0

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

788

2412

1.92

55.35

1.6

1.7

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1308

4663

1.66

55.21

1.1

1.0

—

(40768446) Kidney Pathology biopsy report

105

7.30

55.08

1.8

1.3

—

(3010838) Calcium [Moles/time] in 24 hour Urine

137

148

5.35

55.01

1.8

1.6

mmol/24h

6.8

4.6

1.22

(3027944) Amphetamines [Presence] in Urine

1322

4744

1.65

54.38

2.3

1.3

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

169

228

4.29

53.52

1.7

1.4

u/l

5.3

5.1

0.18

138

206

(21494890) Protein electrophoresis panel - 24 hour Urine

118

114

5.98

52.57

2.6

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

217

363

3.46

52.02

1.1

1.0

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

205

330

3.60

51.87

1.0

mg/l

293.3

283.7

0.71

175

310

(3020876) Protein [Mass/time] in 24 hour Urine

133

149

5.16

51.55

1.8

2.1

g/24h

0.8

1.6

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

122

126

5.59

51.16

1.4

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

202

325

3.60

51.15

1.2

ratio

1.1

0.08

108

(44806118)

199

318

3.62

50.87

1.7

1.5

—

(44790049)

199

318

3.62

50.87

1.7

1.5

—

(40768443) Skin Pathology biopsy report

722

2208

1.91

50.81

1.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

110

102

6.23

50.80

1.6

1.3

e6/l

1807.7

4961.1

2.56

(40768441) Liver Pathology biopsy report

162

221

4.24

50.66

1.3

—

(44790047)

199

319

3.61

50.65

1.7

1.5

—

(44790048)

199

319

3.61

50.65

1.7

1.5

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

179

268

3.86

49.90

1.5

1.2

promille

1.3

1.5

0.95

139

214

(3049717) Cytology report of Urine Cyto stain

376

888

2.46

49.90

2.0

2.3

—

(3011648) Oxygen content in Venous blood

131

150

5.05

49.68

3.5

2.3

11.0

12.5

2.62

131

150

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

194

310

3.62

49.60

1.4

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

131

152

4.98

49.02

1.6

1.5

u/l

5.4

4.8

0.14

(21494755) Public health laboratory ask at order entry panel

2148

16818

0.70

48.28

1.3

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

16.71

47.81

1.8

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

7.72

47.61

2.7

1.6

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

212

373

3.29

47.24

1.2

—

(3022689) Creatine [Moles/volume] in Urine

9.32

47.15

1.7

1.5

—

(3030313) Adrenal Ab [Titer] in Serum

7.33

46.91

1.2

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

794

2571

1.81

46.84

1.7

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

4136

18990

1.32

46.81

2.2

2.0

—

(3010375) cycloSPORINE [Mass/volume] in Blood

6.35

46.52

24.4

17.1

ug/l

118.5

129.3

0.54

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

193

322

3.47

46.49

1.2

1.1

mmol/l

1.9

1.7

2.06

179

305

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3478

15582

1.35

46.44

4.0

2.8

ug/l

1.5

1.9

1.32

3149

14651

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

929

3179

1.71

45.42

2.5

1.7

u/ml

31.1

26.0

0.93

897

3073

(3025468) Yersinia sp identified in Specimen by Organism specific culture

237

459

2.99

45.41

1.5

1.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

310

698

2.58

45.31

1.4

1.3

u/ml

50.6

29.5

0.74

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

237

460

2.99

45.25

1.5

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

237

460

2.99

45.25

1.5

1.2

—

(3036603) Volume of Urine

140

186

4.35

45.21

1.7

1.5

2241.0

1884.6

0.82

(3000093) Morphology [Interpretation] in Blood Narrative

156

227

3.97

45.14

1.2

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

244

484

2.92

44.92

1.5

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

281

604

2.70

44.86

1.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

6.29

44.81

1.2

1.0

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

238

467

2.95

44.62

1.5

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

234

455

2.98

44.55

1.4

1.5

titre

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

6.65

44.43

1.4

1.2

—

(3011412) CD3 cells [#/volume] in Blood

214

396

3.13

44.15

2.3

e9/l

1.2

1.3

0.34

124

200

(3004451) EKG impression Narrative

11.18

44.05

1.2

1.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

6.08

43.98

1.3

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

237

470

2.92

43.66

1.5

1.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

750

2440

1.80

43.55

1.3

1.2

ug/l

3.4

3.5

0.33

705

2338

(3017354) Segmented neutrophils/100 leukocytes in Blood

150

218

3.98

43.49

2.9

2.3

57.9

55.7

0.43

102

132

(3008898) HLA-B27 [Presence]

980

3460

1.66

42.67

1.1

—

(3023419) Bacteria identified in Sputum by Culture

181

311

3.37

41.83

2.8

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

6.43

41.82

1.4

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

148

220

3.89

41.72

3.1

1.8

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

167

273

3.54

41.45

2.1

2.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

25.34

41.37

8.2

5.6

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

112

132

4.90

41.30

1.2

u/l

114.1

66.7

1.70

111

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

111

130

4.93

41.20

1.2

u/l

37.6

10.5

1.15

104

(3017704) Immunofixation for Urine

7.25

40.82

1.6

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

105

5.44

40.56

1.3

1.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

133

187

4.11

40.20

1.9

umol/l

2.1

1.9

1.55

124

180

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

104

5.44

40.14

2.1

1.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

104

5.44

40.14

2.1

1.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

104

5.44

40.14

2.1

1.4

—

(3045788) Cell count panel - Pleural fluid

6.28

40.10

1.6

1.3

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

155

247

3.63

39.87

1.1

nmol/l

1.4

5.5

0.73

(3028308) Erythrocytes [#/volume] in Pleural fluid

5.83

39.79

1.6

1.4

e6/l

13235.5

58334.6

0.94

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

105

5.39

39.77

2.1

1.4

—

(3026389) Candida sp identified in Specimen by Organism specific culture

332

824

2.34

39.71

1.4

1.2

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

100

110

5.25

39.56

1.7

1.8

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

3974

18511

1.30

39.38

1.5

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

278

640

2.52

38.95

1.1

g/l

1.5

1.4

4.56

245

592

(3051593) INR in Capillary blood by Coagulation assay

14.40

38.84

8.3

2.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

834

2892

1.69

38.80

1.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

157

259

3.50

38.51

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

18.51

38.49

5.8

5.2

—

(3045142) Bone marrow Pathology biopsy report

125

174

4.15

38.27

1.4

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

23.60

37.81

8.3

5.6

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

104

5.27

37.78

1.3

1.1

—

(3044927) Protein electrophoresis panel - Urine

114

150

4.39

37.30

1.4

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

7.01

37.27

3.6

2.6

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

113

5.00

37.00

3.1

umol/l

28.2

27.7

0.13

(3016018) Differential panel - Cerebral spinal fluid

238

521

2.65

36.81

1.3

1.2

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

137

212

3.73

36.70

1.1

96.7

93.3

0.45

106

160

(40768806) Pleura Pathology biopsy report

5.57

36.10

1.7

1.5

—

(3045414) Leukocytes [Presence] in Urine

771

2669

1.69

36.08

1.7

1.5

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

200

404

2.86

35.79

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

198

398

2.88

35.73

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

200

405

2.86

35.64

1.2

1.1

—

(3042631) Mycobacterium sp identified in Specimen

154

265

3.36

35.58

2.4

2.9

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

197

396

2.88

35.55

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

200

406

2.85

35.49

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

197

398

2.86

35.25

1.2

1.1

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

145

241

3.48

35.23

2.0

1.8

93.8

101.9

1.75

132

217

(3044242) Glucose [Moles/volume] in Arterial blood

6.71

35.02

1.8

1.3

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

151

260

3.36

34.87

1.2

u/ml

18.7

6.0

0.52

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

101

127

4.59

34.81

1.2

u/l

27.6

13.3

1.16

107

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

219

473

2.68

34.76

2.8

2.2

u/ml

28.8

348.3

0.45

210

373

(3019977) pH of Arterial blood

5.70

34.72

3.1

1.5

7.4

0.69

(3033705) Calcium.ionized [Moles/volume] in Venous blood

130

202

3.72

34.66

2.8

1.4

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

102

130

4.53

34.63

1.2

u/l

82.7

73.1

0.47

110

(4094501)

395

1120

2.05

34.35

1.1

1.0

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

13.64

34.14

1.8

1.2

nmol/l

164870.3

1228576.5

0.82

(3006922) Hepatitis E virus Ab [Presence] in Serum

177

345

2.97

33.68

1.1

—

(3012441) Differential panel - Pleural fluid

5.43

33.22

1.8

1.4

—

(1175426) CD3 cells/100 lymphocytes in Blood

167

318

3.04

33.03

1.9

2.0

72.0

74.7

1.46

160

313

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

10.28

32.93

1.7

4.4

mmol/l

2.1

1.2

0.64

(3034426) Prothrombin time (PT)

112

4.74

32.86

1.3

1.2

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

145

253

3.31

32.86

1.6

1.4

umol/l

26.0

25.6

0.05

138

247

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

166

316

3.04

32.85

1.9

2.0

12.9

12.8

0.06

173

(3023410) Appearance of Cerebral spinal fluid

226

512

2.55

32.77

1.5

1.3

—

(3006270) Folate [Moles/volume] in Blood

167

320

3.02

32.70

1.1

nmol/l

389.4

397.8

0.19

154

306

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

583

1922

1.77

32.40

1.3

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

239

560

2.47

32.39

1.2

1.1

mg/l

37.2

40.5

0.53

201

462

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

126

202

3.60

32.24

1.2

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

230

532

2.50

32.01

1.1

1.0

—

(3036782) Glucose [Moles/volume] in Pleural fluid

130

4.35

31.83

1.5

1.2

mmol/l

5.9

5.2

2.39

119

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

387

1124

2.00

31.58

1.5

1.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

193

412

2.71

31.36

1.2

1.3

—

(3051651) Icteric interference index of Serum or Plasma

134

4.22

30.74

3.9

2.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

6.03

30.72

1.5

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

6.03

30.72

1.5

1.7

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

191

411

2.69

30.59

1.2

1.3

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

186

395

2.72

30.52

1.1

1.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

117

186

3.63

30.31

1.1

1.0

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

120

195

3.55

30.17

1.1

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

10.36

29.78

4.2

4.6

ug/min

47.8

13.6

3.03

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

160

318

2.91

29.53

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

228

548

2.41

29.35

1.1

1.0

mg/l

232.4

219.2

0.45

197

488

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

616

2131

1.68

28.90

1.2

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

160

323

2.86

28.76

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

8.23

28.71

1.6

1.4

mu/l

146.7

42.4

1.66

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

158

318

2.87

28.55

2.3

2.4

e9/l

0.2

1.07

130

260

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

104

159

3.77

28.42

1.9

2.0

umol/l

28.9

28.3

0.21

153

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

135

249

3.13

28.18

1.3

1.1

68.6

91.0

1.67

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

164

341

2.78

28.00

1.2

u/ml

16.4

6.9

0.41

(3051611) Lipemic interference index of Serum or Plasma

145

281

2.98

27.95

3.5

1.9

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

6.72

27.73

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

232

578

2.32

27.67

1.1

1.0

—

(21494815) CD4 cells/100 lymphocytes in Specimen

184

410

2.59

27.64

2.2

2.3

40.5

46.6

1.05

(3003338) MCHC [Mass/volume]

14362

78392

1.23

27.62

18.0

6.2

g/l

333.0

334.0

33.00

14278

77632

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

2482

11326

1.30

27.54

2.0

1.9

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

648

2303

1.64

27.46

1.7

1.6

iu/ml

26.6

0.5

0.49

125

420

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

5.23

27.37

2.3

1.5

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

5.23

27.37

2.3

1.5

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

124

4.14

27.34

13.4

1.2

mg/l

2099.1

16303.6

1.60

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

158

327

2.79

27.22

2.3

2.4

e6/l

521.7

513.7

0.07

128

261

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

166

354

2.71

27.09

1.2

u/ml

38.8

57.9

0.37

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

117

202

3.34

27.02

1.7

1.4

—

(3047189) Immunofixation for 24 hour Urine

6.76

26.88

2.1

1.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

294

819

2.08

26.87

3.2

2.2

—

(3000330) Specific gravity of Urine by Test strip

627

2223

1.64

26.82

2.9

2.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

166

356

2.69

26.82

1.2

u/ml

60.1

29.9

0.66

(3000492) Spirometry study

1788

7815

1.35

26.80

1.4

1.3

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

162

343

2.73

26.79

2.5

e6/l

781.1

879.2

0.74

139

(3038026) Centromere Ab [Units/volume] in Serum

168

363

2.67

26.77

1.2

u/ml

46.2

19.9

0.59

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

106

172

3.56

26.76

1.1

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

118

207

3.29

26.62

1.6

1.5

iu/ml

1212300.0

374562.8

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

4.98

26.44

1.4

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

4.98

26.44

1.4

1.1

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

172

381

2.61

26.16

1.3

titre

121.3

270.0

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

172

381

2.61

26.16

1.3

titre

198.5

158.0

0.25

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1860

13672

0.76

25.85

1.7

1.5

—

(4027681)

191

450

2.45

25.70

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

119

215

3.19

25.69

1.2

1.3

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

252

673

2.17

25.62

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

4.76

25.58

1.9

1.2

u/ml

2890.7

2257.2

—

(40757494) Bilirubin.total [Moles/volume] in Blood

114

4.15

25.29

2.6

2.4

umol/l

14.6

47.7

—

(21494434) Karyotype in Bone marrow

143

3.75

25.27

1.2

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

8.17

25.18

2.5

1.5

e6/l

1020.9

1396.4

0.15

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

4.75

25.16

2.3

1.5

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

149

314

2.74

24.89

1.6

—

(3045424) Erythrocytes [Presence] in Urine

338

1023

1.91

24.65

1.5

1.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

336

1020

1.91

24.29

1.7

1.6

e6/l

9976.2

10089.9

0.02

259

756

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

156

342

2.63

24.24

1.3

1.2

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

8.43

23.96

1.8

1.2

g/l

12.9

10.3

0.54

(3035880) pH of Pleural fluid

6.94

23.90

1.3

1.2

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

7.74

23.70

1.3

1.2

pmol/l

344.8

279.1

0.72

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

654

2416

1.58

23.70

1.4

1.3

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

8.53

23.56

1.2

1.3

ng/l

38.8

48.2

0.19

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

6.26

23.40

1.2

1.1

—

(3000012) Reticulocyte production index

101

4.22

23.36

1.5

1.3

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

367

1163

1.83

23.30

1.8

2.0

titre

8.9

8.1

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

+∞

23.22

8.2

0.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

167

3.38

23.14

1.2

1.3

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

166

386

2.48

23.00

1.1

u/l

1.0

0.56

159

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

8.31

22.59

2.1

1.4

e6/l

2500.2

15806.1

—

(3017569) Oxygen content in Arterial blood

5.21

22.59

1.9

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1954

8857

1.30

22.50

1.9

1.8

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1259

9606

0.74

22.49

1.4

1.3

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

298

893

1.93

22.41

1.2

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

+∞

22.39

1.6

0.0

nmol/l

509.3

—

(3028717) Thiamine [Mass/volume] in Blood

8.87

22.36

1.1

1.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

188

470

2.31

22.35

2.0

1.6

mg/l

27.7

26.2

0.12

120

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

103

186

3.19

22.32

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

238

662

2.08

21.93

1.8

1.6

iu/ml

27.2

35.5

0.32

(40765096) Chromosome analysis panel by Banding

6.88

21.74

1.0

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

963

3929

1.43

21.67

1.9

1.3

mg/l

4.0

2.7

4.53

740

2272

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

172

3.25

21.63

2.5

umol/l

54.0

52.9

0.12

161

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

5.76

21.35

1.5

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

4.35

21.31

1.9

1.8

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

6.17

20.83

7.5

1.5

u/l

43.4

106.6

0.45

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

123

258

2.75

20.81

2.0

126.8

109.9

1.78

116

250

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

5.34

20.73

3.9

1.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

5.34

20.73

3.9

1.5

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

171

3.20

20.72

1.0

ng/l

39.8

42.5

0.18

131

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

172

3.18

20.54

1.0

ng/l

856.2

709.5

1.54

127

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

172

3.18

20.54

1.0

ng/l

282.5

316.9

0.46

136

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

7.24

20.52

1.2

1.1

—

(3022621) pH of Urine by Test strip

972

4020

1.41

20.28

2.7

2.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

5.00

20.21

1.2

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

189

499

2.19

19.87

1.3

u/ml

1.2

1.4

0.13

180

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

457

1617

1.64

19.79

1.6

1.4

pmol/l

83.1

55.4

1.97

441

1574

(4034850)

516

1883

1.59

19.74

10.8

4.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

382

1289

1.72

19.73

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

316

1008

1.81

19.72

2.5

2.6

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1216

5252

1.35

19.52

1.4

1.5

—

(3014271) Vancomycin [Susceptibility]

4.98

19.36

2.4

1.8

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

5.76

19.20

2.0

1.5

pmol/l

34.5

28.1

0.18

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

5.89

19.16

1.7

1.5

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

12.46

18.93

1.1

1.0

mmol/l

—

(1761868) Lipid panel - Serum or Plasma

6870

35820

1.16

18.89

2.8

1.9

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

3.88

18.87

1.1

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

287

903

1.84

18.73

1.2

1.3

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

20.45

18.60

1.1

1.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

203

571

2.05

18.26

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

13319

73021

1.17

18.19

3.8

3.4

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

32.21

18.18

10.1

7.2

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

100

202

2.85

18.15

1.3

1.1

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

9.27

18.02

1.0

mg/l

59.2

32.7

—

(3019832) Treponema pallidum Ab [Presence] in Serum

3720

18522

1.19

17.78

1.8

1.7

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

134

321

2.41

17.59

1.5

1.2

—

(3021788) Differential panel - Synovial fluid

265

830

1.85

17.58

1.6

1.5

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

107

230

2.68

17.40

2.7

2.9

43.4

42.6

0.10

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.80

17.29

1.1

1.0

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

104

223

2.69

17.00

1.1

1.2

g/l

0.3

0.47

178

(44813793)

190

537

2.04

16.92

1.0

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

151

3.09

16.82

2.0

2.1

e6/l

190.0

201.5

0.10

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

157

413

2.19

16.74

1.7

1.5

38.7

41.4

0.31

272

(3033799) Differential panel - Peritoneal fluid

7.43

16.65

2.6

1.7

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

934

3971

1.37

16.56

1.4

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

129

3.26

16.47

1.2

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

571

2223

1.49

16.40

2.1

2.4

umol/l

5.4

5.3

0.14

408

1652

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

148

3.08

16.29

1.3

titre

71.3

113.7

—

(3045716) Anion gap in Serum or Plasma

3.72

16.28

2.0

2.1

mmol/l

9.8

8.9

0.50

(21494814) CD8 cells/100 lymphocytes in Specimen

142

3.12

16.28

1.9

2.0

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

186

2.82

16.23

1.2

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

196

2.76

16.19

1.2

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

180

2.85

16.17

1.4

1.5

u/ml

12.0

20.3

1.75

(3044007) Cell count panel - Peritoneal fluid

7.13

16.16

1.7

1.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

421

1538

1.59

16.11

1.1

u/ml

3.1

3.4

0.23

226

942

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

123

3.28

15.94

1.7

1.6

nmol/l

0.2

0.3

1.76

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.77

15.79

1.1

1.0

—

(3001556) Androgen free Index in Serum or Plasma

121

3.28

15.76

1.4

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

138

353

2.26

15.74

1.2

1.6

ug/l

6.0

8.2

0.85

122

315

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

106

241

2.54

15.54

3.4

4.5

—

(3001186) Copper [Moles/volume] in Serum or Plasma

102

3.50

15.53

1.5

1.2

umol/l

17.6

16.5

0.53

(3045683) HLA typing for celiac disease panel - Blood or Tissue

190

555

1.98

15.53

1.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

191

2.75

15.51

1.4

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

117

280

2.41

15.45

1.1

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

5.93

15.27

2.4

1.9

pmol/l

46.5

49.7

0.13

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

6.61

15.24

2.4

1.2

mmol/l

6.5

5.6

0.69

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

6.35

15.24

1.3

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

3.53

15.19

2.3

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

210

2.63

15.17

1.1

1.2

110.7

106.0

0.89

186

(40761539) Cells [Type] in Urine sediment by Light microscopy

4.19

15.15

1.5

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

12.08

15.04

1.0

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

4.09

15.03

1.3

1.6

—

(3044941) Cell count panel - Synovial fluid

214

659

1.88

15.03

1.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

504

1948

1.50

15.02

1.1

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

+∞

14.92

1.2

0.0

nmol/l

55.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

3.50

14.81

1.1

1.0

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

3.47

14.61

1.4

1.1

nmol/l

135.6

110.7

0.57

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

294

1007

1.69

14.52

1.7

1.8

titre

4560.0

3791.7

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

378

1382

1.58

14.46

1.2

1.1

au/ml

17.0

12.1

0.43

121

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

138

3.01

14.36

1.2

1.1

14.0

9.4

0.23

(44806071)

4.04

14.22

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2631

12943

1.20

14.02

3.7

2.7

22.7

22.4

0.41

992

4643

(3028433) Virus identified in Specimen by Culture

134

3.01

14.00

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

141

383

2.12

14.00

3.0

1.7

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

7.06

13.98

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

482

1882

1.48

13.71

1.5

1.4

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

106

3.26

13.61

1.1

1.0

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

5.75

13.59

1.1

umol/24h

0.7

0.21

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

108

3.20

13.25

1.1

1.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

131

2.95

12.98

1.5

1.7

ug/l

9.6

8.3

1.31

131

(3014148) Varicella zoster virus Ab [Titer] in Serum

353

1306

1.56

12.90

1.2

—

(3020491) Glucose [Moles/volume] in Blood

162

479

1.95

12.89

1.8

1.3

mmol/l

6.4

5.2

3.95

113

384

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

174

2.65

12.85

1.1

1.0

—

(3009871) Measles virus Ab [Titer] in Serum

101

250

2.33

12.51

1.9

1.7

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

346

1286

1.56

12.41

1.2

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

181

2.58

12.38

1.3

1.2

106.7

113.5

0.60

163

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

5.56

12.34

2.9

1.3

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

223

2.40

12.33

1.2

u/l

294.9

353.3

0.16

214

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

184

577

1.84

12.32

1.8

1.6

48.2

47.1

0.12

112

404

(3008536) Aspergillus sp Ab [Presence] in Serum

4.58

12.27

2.1

1.8

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

337

1251

1.56

12.16

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

146

427

1.97

12.01

1.1

1.0

miu/ml

1531.2

1364.9

0.91

146

427

(3005082) Progesterone [Moles/volume] in Serum or Plasma

302

1097

1.59

11.96

1.4

1.3

nmol/l

28.3

34.2

3.16

275

1042

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

7.44

11.85

1.0

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

974

4379

1.29

11.81

1.3

miu/ml

236.4

231.7

0.14

486

2317

(3024263) Appearance of Synovial fluid

207

2.42

11.75

2.4

2.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

265

940

1.63

11.57

1.6

1.2

—

(3026726) Creatinine [Moles/volume] in Specimen

8.21

11.53

3.0

1.4

umol/l

523.5

692.5

0.19

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

179

2.51

11.35

1.2

1.1

90.0

96.6

0.88

(3024869) Neuronal Ab [Presence] in Serum

4.14

11.30

1.0

—

(3032057) Clostridioides difficile [Presence] in Stool

4.41

11.15

1.9

1.7

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

5.36

11.12

2.6

1.8

—

(3029075) Extractable nuclear Ab panel - Serum

144

2.68

11.07

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

5.54

11.04

1.3

1.4

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

175

2.50

11.00

1.3

1.1

89.0

99.8

1.30

(3041918) Cholesterol [Moles/volume] in Pleural fluid

7.10

10.94

1.1

1.2

mmol/l

1.5

2.8

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

6.00

10.94

5.3

2.2

umol/l

37.3

49.3

0.89

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

6.30

10.92

1.3

1.4

ug/l

36.0

193.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

180

585

1.78

10.81

1.2

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

140

420

1.92

10.77

1.7

1.2

umol/l

63.4

70.8

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

20.69

10.73

2.8

3.0

mu/l

2.4

—

(40768800) Prostate Pathology biopsy report

130

381

1.97

10.69

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

3.02

10.60

4.3

4.7

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

158

2.55

10.56

1.1

1.2

—

(3048879) Bone marrow aspiration report

5.01

10.43

2.3

1.3

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

5.16

10.34

1.7

1.2

g/l

24.3

20.8

0.34

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

836

3755

1.29

10.25

1.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

133

400

1.92

10.19

1.4

e6/l

66027.7

38790.7

0.25

269

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

124

2.74

10.18

1.1

1.0

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

4.42

10.18

1.1

1.0

—

(3017509) Phencyclidine [Presence] in Urine

3.07

10.04

1.8

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

197

2.31

9.73

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

149

2.51

9.55

2.9

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

101

284

2.05

9.35

3.1

1.3

ug/l

22.8

763.1

1.29

271

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

257

2.11

9.35

1.1

1.3

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

8.36

9.32

1.6

1.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

121

2.66

9.23

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

7.52

9.23

1.2

mmol/l

1.7

5.1

—

(3036180) Methadone [Presence] in Urine

+∞

9.12

3.2

0.0

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

204

2.23

9.03

1.1

ng/l

134.8

264.5

0.45

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

121

369

1.89

8.96

1.1

u/ml

6.1

15.2

2.33

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

5.75

8.81

1.3

1.0

—

(4281824)

133

422

1.82

8.74

1.2

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.20

8.67

1.0

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

129

2.54

8.63

1.3

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

276

2.00

8.43

1.1

1.3

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

4.09

8.41

1.1

40.2

80.1

2.47

(3032352) Blasts [#/volume] in Cerebral spinal fluid

7.84

8.38

4.0

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

5.75

8.37

4.4

1.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

265

1019

1.50

8.31

1.4

1.5

mmol/l

12.7

7.8

3.63

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.81

8.23

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.81

8.23

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.81

8.23

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.81

8.23

1.2

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

109

2.64

8.15

1.3

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

348

1417

1.42

8.15

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

696

5026

0.79

8.13

2.0

1.9

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

144

2.40

8.10

1.5

1.3

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

269

1.99

8.05

1.6

1.5

u/field

2.7

3.2

0.19

195

(3014051) Protein [Presence] in Urine by Test strip

321

1300

1.43

7.77

2.0

1.7

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

112

351

1.84

7.71

1.8

1.6

u/field

2.2

0.04

175

(3002619) Bacteria identified in Specimen by Culture

2.84

7.65

1.2

1.0

—

(4024509)

136

454

1.73

7.61

1.6

1.3

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

5.45

7.57

1.2

1.1

umol/24h

1.6

1.3

0.95

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

3.45

7.55

1.0

—

(3019174) dRVVT (LA screen)

3.36

7.53

1.3

1.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

129

2.41

7.39

2.8

1.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.77

7.35

1.0

—

(3044009) aPTT.lupus sensitive (LA screen)

3.30

7.33

1.3

1.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.74

7.29

1.0

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

113

2.50

7.22

1.3

41.9

51.8

0.85

(4015189)

3.00

7.18

2.1

1.6

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

3.17

7.15

1.4

1.3

ng/l

120.7

77.6

1.04

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

5.43

7.13

1.6

1.5

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

226

2.01

7.10

1.8

1.5

4.8

6.0

0.21

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

3.34

6.98

1.0

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

9.58

6.90

2.3

5.0

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

102

2.54

6.87

1.1

80.3

100.6

0.92

(3039443) Prostate specific Ag panel - Serum or Plasma

240

1970

0.70

6.85

1.6

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

157

562

1.61

6.82

1.1

iu/ml

7.6

7.2

0.05

168

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.07

6.80

1.1

1.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

4.55

6.71

1.0

u/l

20.7

10.5

0.32

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

4.55

6.71

1.5

1.1

ml/s/173m2

1.3

5.3

0.57

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

3.48

6.64

2.3

1.9

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

4.70

6.58

1.8

1.4

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

6.79

6.55

1.3

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

171

2.12

6.52

1.1

1.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

326

1369

1.37

6.48

3.6

2.3

mg/l

24.1

25.7

0.33

195

816

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

13.80

6.48

1.0

1.2

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

13.80

6.48

4.1

4.0

—

(3007463) Buprenorphine [Presence] in Urine

13.80

6.48

4.4

4.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

172

2.11

6.43

1.1

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

172

2.11

6.43

1.1

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

151

545

1.60

6.38

1.4

1.3

—

(44806420)

5.11

6.35

2.1

2.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

379

1636

1.34

6.33

1.3

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

6.23

6.13

1.7

1.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.53

6.11

2.0

1.6

—

(3020393) Adenovirus Ag [Presence] in Stool

3.17

6.06

1.5

1.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

173

2.06

6.01

1.1

1.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

415

0.40

5.93

3.1

3.5

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

415

0.40

5.93

6.1

6.9

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.44

5.87

1.0

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

104

2.38

5.82

1.2

1.1

65.1

87.7

0.89

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

+∞

5.80

1.3

0.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

144

528

1.57

5.75

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

180

694

1.49

5.73

1.5

1.6

—

(3025577) Chromium [Mass/volume] in Blood

181

2.00

5.69

1.9

2.2

ug/l

2.1

2.8

0.63

159

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

8.30

5.66

2.5

4.3

—

(3026470) Cobalt [Mass/volume] in Blood

186

1.98

5.61

1.9

2.1

ug/l

2.3

3.0

0.72

170

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.21

5.51

1.1

1.0

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

2.78

5.49

1.9

1.6

mg/l

1.2

1.7

0.42

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

137

2.14

5.47

2.5

1.5

ng/l

106.3

95.2

0.19

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

145

2.10

5.44

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.70

5.39

1.5

1.4

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

3.45

5.35

1.0

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

4.54

5.30

1.8

1.5

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

2.73

5.16

1.9

1.6

mg/l

0.5

1.2

1.28

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

2.73

5.16

1.9

1.6

mg/l

1.8

3.3

0.59

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

2.73

5.16

1.9

1.6

mg/l

1.8

3.9

1.02

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

2.73

5.16

1.9

1.6

mg/l

1.2

1.8

0.38

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

2.73

5.16

1.9

1.6

mg/l

0.8

2.0

1.13

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

2.73

5.16

1.9

1.6

mg/l

1.9

0.02

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

2.73

5.16

1.9

1.6

mg/l

0.8

1.2

0.26

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

2.73

5.16

1.9

1.6

mg/l

2.8

5.5

1.14

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

2.73

5.16

1.9

1.6

mg/l

0.9

3.9

2.57

(3013466) aPTT in Blood by Coagulation assay

3.35

5.15

1.1

36.2

36.4

0.08

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

3.15

5.15

1.1

1.0

—

(3024316) Viscosity of Plasma

11.50

5.13

1.0

mpas

1.3

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

111

2.23

5.09

1.1

u/ml

0.0

0.1

0.56

(3028679) Herpes simplex virus Ab [Presence] in Serum

149

568

1.51

5.06

1.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.70

5.03

2.2

—

(3025315) Body weight

4.31

5.02

4.1

1.2

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

+∞

4.97

3.5

0.0

—

(3008717) Parietal cell Ab [Titer] in Serum

+∞

4.97

1.2

0.0

titre

1411.7

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

+∞

4.97

1.0

0.0

—

(3036670) Protein [Mass/volume] in Synovial fluid

2.33

4.95

1.5

1.2

g/l

37.1

43.0

1.27

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.40

4.87

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

354

1580

1.29

4.78

1.4

1.5

mmol/l

7.1

6.2

5.53

253

1097

(3020650) Glucose [Presence] in Urine

228

1.79

4.70

1.4

1.3

—

(3022475) Manganese [Moles/volume] in Blood

3.62

4.64

1.4

1.3

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

548

2587

1.22

4.59

1.1

u/ml

1.8

0.02

218

1100

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

2.60

4.58

1.8

1.6

ug/l

10.9

1.6

0.46

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

3.92

4.52

2.7

2.3

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

305

1.66

4.49

1.1

1.0

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

3.68

4.46

1.2

1.0

—

(3013336) Amino acids [Identifier] in Serum or Plasma

4.40

4.45

4.4

2.8

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

4.40

4.45

1.5

1.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1877

9762

1.12

4.45

2.7

2.2

ug/l

0.6

0.7

3.41

1096

4568

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

3.21

4.41

1.1

1.0

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

2.34

4.41

1.2

1.1

mg/l

0.7

31.5

0.49

(3003888) Timothy IgE Ab [Units/volume] in Serum

495

2324

1.23

4.39

1.1

u/ml

5.6

6.3

0.37

267

1304

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.94

4.28

1.8

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

430

1998

1.24

4.22

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.75

4.20

1.0

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

4.15

4.19

1.0

u/ml

0.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

+∞

4.15

1.6

0.0

—

(4212803)

8.62

4.13

1.0

1.2

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

3.83

4.11

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

429

1999

1.24

4.11

1.1

—

(3001729) Color of Synovial fluid

3.59

4.07

1.4

1.5

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

164

1.86

3.99

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

6.39

3.89

1.4

1.0

mmol/24h

129.7

124.9

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

125

1.98

3.88

1.0

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.51

3.72

1.2

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

3.74

3.71

1.0

u/ml

0.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

152

1.85

3.69

1.2

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.21

3.59

1.3

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

129

518

1.43

3.52

1.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.11

3.46

1.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

4.42

3.45

1.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

464

2224

1.20

3.44

1.1

u/ml

1.0

1.1

0.10

198

1020

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

136

1.86

3.38

1.1

1.0

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

6.57

3.25

3.0

6.7

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.14

3.23

1.3

1.2

—

(46236302) HLA-C [Type] by High resolution typing

8.05

3.20

1.1

1.0

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

8.05

3.20

1.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

8.05

3.20

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

4.11

3.19

1.2

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.46

3.18

1.7

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2.39

3.13

1.3

1.4

nmol/l

20.1

15.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

5.17

3.11

1.6

1.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

136

1.82

3.11

1.3

1.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

137

1.81

3.04

2.8

2.4

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

5.75

3.01

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

5.75

3.01

1.0

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

5.75

3.01

1.3

1.1

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

5.75

3.01

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

5.75

3.01

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

5.75

3.01

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

5.75

3.01

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

5.75

3.01

2.0

—

(40758292) HTLV I+II Ab panel - Serum

2.00

2.96

1.4

1.2

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

3.83

2.95

1.3

1.0

35.8

35.3

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.30

2.91

2.0

1.6

—

(3052592) Norovirus Ag [Presence] in Stool

2.52

2.87

1.5

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

2747

14845

1.07

2.81

1.5

1.4

—

(3050794) Legionella sp Ab [Presence] in Serum

2.69

2.70

1.0

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

186

830

1.29

2.70

1.2

—

(3049233) Organic acids panel - Urine

5.75

2.69

1.0

—

(40757373) Influenza virus identified in Isolate

2.24

2.64

1.4

1.6

—

(40763590) HLA-DQ beta [Type]

6.90

2.60

1.2

1.0

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

234

1.55

2.60

1.1

u/ml

1.1

12.9

1.97

169

(3016031) Almond IgE Ab [Units/volume] in Serum

1.96

2.57

1.1

1.0

u/ml

0.1

1.1

3.25

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.61

2.57

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

352

1.44

2.56

1.2

1.1

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

129

1.74

2.50

1.1

1.0

u/ml

0.1

1.0

1.13

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

141

614

1.32

2.48

1.3

1.5

mmol/l

5.4

5.0

3.49

129

593

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

195

887

1.27

2.47

1.4

1.3

pmol/l

371.9

78.3

0.52

169

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.77

2.46

1.2

1.0

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

322

1.45

2.45

1.1

u/ml

0.5

17.8

1.66

202

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

3.69

2.41

1.0

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

3.69

2.41

1.3

1.0

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

131

1.71

2.39

1.1

1.0

u/ml

0.0

4.3

0.76

(3015183) Erythrocyte sedimentation rate

131

569

1.32

2.36

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

107

451

1.37

2.34

1.8

2.0

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.97

2.34

1.1

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

816

5199

0.90

2.29

1.4

1.5

—

(3040893) Potassium [Moles/volume] in Capillary blood

4.47

2.28

4.1

3.4

mmol/l

4.5

4.3

—

(3005033) Fetal Nuchal fold Thickness US

814

5185

0.90

2.28

1.4

1.5

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

3.45

2.27

1.7

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.39

2.20

1.1

1.3

—

(4211845)

326

1.41

2.16

2.6

2.0

—

(3013862) HLA-DP [Type]

4.93

2.15

1.2

1.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

835

5292

0.90

2.14

1.5

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

114

1.71

2.13

1.4

40.6

43.6

0.16

(3025130) Human papilloma virus identified in Specimen

345

1692

1.17

2.12

1.7

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

499

3254

0.88

2.10

1.2

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.49

2.07

1.3

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.24

2.07

1.1

1.0

—

(3020874) Milk IgE Ab [Units/volume] in Serum

176

811

1.25

2.06

1.1

u/ml

0.5

4.8

1.13

225

(3006462) Nitrate [Presence] in Urine

296

1.42

2.04

2.7

2.0

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

129

1.65

2.03

1.1

1.0

u/ml

0.0

0.3

1.63

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

5.75

2.03

1.0

1.6

nmol/l

313.2

231.2

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

2.55

2.00

1.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

139

625

1.28

2.00

1.8

1.9

—

(3018001) Oat IgE Ab [Units/volume] in Serum

1.84

1.98

1.0

1.1

u/ml

0.2

2.3

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

3.28

1.97

3.0

2.6

umol/l

42.1

44.9

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.66

1.96

1.3

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

3.66

1.96

7.0

1.5

—

(3009015) Lactate [Moles/volume] in Synovial fluid

2.41

1.95

1.2

1.3

mmol/l

7.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.95

1.7

1.5

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

122

1.65

1.93

1.1

1.0

u/ml

0.2

0.5

0.94

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.84

1.90

1.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.87

1.89

1.0

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.21

1.89

1.1

1.3

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.99

1.86

1.3

1.8

—

(3036071) Salmonella sp Ab [Titer] in Serum

283

1.40

1.85

1.0

1.1

—

(3018291) Platelet Ab [Presence] in Serum

4.79

1.82

1.4

1.5

—

(3011897) Casein IgE Ab [Units/volume] in Serum

184

1.50

1.81

1.2

1.3

u/ml

0.1

12.3

0.95

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

1.89

1.80

1.7

1.4

ug/l

0.4

0.12

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

3.83

1.80

1.0

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

2.61

1.75

1.0

—

2.2

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

1.83

1.74

3.2

1.5

25.5

2.8

—

(3029612) Listeria sp Ab [Titer] in Serum

2.26

1.73

1.3

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

368

1848

1.15

1.73

1.1

u/ml

6.4

5.5

0.20

146

800

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.79

1.69

1.0

1.1

—

(3033942) Copper [Moles/time] in 24 hour Urine

2.43

1.69

1.4

1.0

umol/24h

2.5

0.3

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

174

825

1.21

1.63

1.0

1.1

u/ml

3.3

4.0

0.09

201

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.70

1.63

1.2

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

449

2295

1.13

1.63

1.1

u/ml

1.6

2.7

1.00

110

605

(3035933) Granulocytes/100 leukocytes in Blood

263

1.38

1.57

2.4

1.3

—

(3041806) Other cells [#/volume] in Blood by Manual count

154

727

1.22

1.53

1.6

1.4

—

(3051101) Glucose [Moles/volume] in Cord blood

2.39

1.50

4.9

1.5

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

389

1983

1.13

1.50

1.1

u/ml

3.6

5.5

1.28

152

814

(3034092) Cytoplasmic Ig cells/100 cells in Blood

113

1.58

1.50

11.1

2.9

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

113

1.58

1.50

1.0

1.1

—

(3049242) von Willebrand panel - Platelet poor plasma

2.68

1.46

1.6

1.3

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

1.71

1.43

1.0

u/ml

0.2

4.8

1.43

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

134

629

1.23

1.43

1.3

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

153

729

1.21

1.41

1.1

—

(40762814) Titanium [Mass/volume] in Blood

1.84

1.40

2.2

2.5

ug/l

3.3

7.3

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.87

1.40

1.2

1.0

—

(3016135) IgD [Mass/volume] in Serum

2.87

1.40

1.2

mg/l

27.0

70.3

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

1.63

1.40

1.1

u/ml

3.9

12.1

1.88

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

2.30

1.39

1.0

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.92

1.38

1.0

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.76

1.37

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

3.19

1.35

1.0

1.8

3.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

315

1599

1.13

1.33

1.1

1.0

u/ml

0.7

0.4

0.22

319

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.84

1.32

1.3

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

174

1.42

1.32

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.92

1.30

1.0

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

396

1.26

1.25

1.0

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

1.72

1.23

1.1

1.2

u/ml

11.4

28.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

119

563

1.22

1.3

1.4

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

1.21

0.0

1.3

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

130

1.46

1.18

1.1

u/ml

0.0

4.0

1.74

104

(3005011) Chlamydia sp Ab [Titer] in Serum

112

1.49

1.14

1.8

1.4

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

160

784

1.17

1.14

1.0

u/ml

0.3

1.4

0.85

103

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

2.09

1.13

1.0

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

2.37

1.12

1.9

1.2

2.3

3.7

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

2.61

1.12

2.8

1.9

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

899

4847

1.07

1.12

1.5

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

2.05

1.11

1.0

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

1.56

1.10

1.2

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1050

6387

0.94

1.10

1.4

1.5

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

394

1.24

1.08

1.1

1.0

u/ml

6.5

12.0

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1045

6354

0.94

1.08

1.4

1.5

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1050

6382

0.94

1.08

1.4

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1048

6370

0.94

1.08

1.4

1.5

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.61

1.04

1.3

1.8

u/field

0.6

0.7

0.34

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

229

0.70

1.04

1.9

1.8

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

193

1.34

1.03

1.1

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.46

0.98

1.2

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.47

0.95

1.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

2.15

0.90

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

158

1.35

0.90

1.3

1.4

—

(3000285) Sodium [Moles/volume] in Blood

1.85

0.88

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

105

1.42

0.87

1.1

1.2

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.66

0.83

1.0

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1137

6824

0.95

0.79

1.5

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.78

0.78

1.0

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.72

0.77

1.0

1.1

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

135

1.32

0.70

1.1

u/ml

0.0

3.9

2.31

102

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

374

1.18

0.70

5.6

6.5

u/ml

1178.3

9362.8

0.53

(3001218) Citrate [Mass/time] in 24 hour Urine

1.92

0.69

1.2

1.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

366

2259

0.93

0.68

1.7

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1121

6189

1.04

0.67

1.6

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

292

1814

0.92

0.65

1.6

1.5

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.80

0.65

1.0

1.8

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.49

0.65

1.1

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

122

620

1.13

0.63

2.8

3.2

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

201

1.23

0.60

1.0

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.36

0.58

4.9

3.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

2200

12332

1.03

0.58

1.5

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

626

0.89

0.51

1.4

1.2

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.60

0.43

1.2

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.38

0.39

1.4

1.2

umol/24h

313.9

301.0

0.07

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

444

0.89

0.38

3.2

3.5

mg/l

6.9

8.7

1.79

366

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.27

0.38

1.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.62

0.37

1.2

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1050

5879

1.03

0.36

1.8

—

(46235168) Fasting glucose [Moles/volume] in Blood

121

0.81

0.32

1.4

1.1

mmol/l

6.8

5.5

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

1.26

0.30

1.1

—

(3022670) pH of Venous cord blood

1.24

0.27

1.1

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

1.31

0.25

1.2

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

0.22

0.0

1.2

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.22

0.0

1.0

—

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.23

0.20

1.0

—

(3006598) pH of Arterial cord blood

0.85

0.17

1.2

1.0

—

(4038314)

103

1.12

0.13

1.2

1.1

—

(4133840)

304

1.06

0.12

1.3

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1417

8207

0.99

0.11

1.5

1.4

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.17

0.11

1.1

mmol/l

8.9

8.4

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.10

0.10

1.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.10

0.10

1.2

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

324

1888

0.99

0.08

1.5

1.6

mmol/l

7.7

7.2

2.84

208

1078

(3019897) Erythrocyte distribution width [Ratio] by Automated count

330

1871

1.01

0.07

3.2

1.7

13.1

13.0

0.72

324

1840

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

109

1.05

0.03

1.1

1.0

u/ml

0.1

1.8

0.99

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

377

1.02

0.03

1.9

2.0

mg/l

9.9

10.4

0.30

309

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

404

0.98

0.03

2.9

au/ml

125.4

114.2

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.95

0.02

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

556

0.99

0.01

1.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

128

740

0.99

0.01

1.3

1.2

g/l

1.3

1.5

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

1.04

0.00

1.7

1.3

mg/l

1.5

1.6

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

118

1.02

0.00

2.2

2.7

—

(3003157) Bacteria [#/volume] in Mother's milk

0.94

0.00

5.4

6.6

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.99

0.00

1.0

1.1

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: HYPOTHYROIDISM – Hypothyroidism (congenital or acquired)

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Hypothyroidism (congenital or acquired)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints